<SEC-DOCUMENT>0000939767-20-000067.txt : 20200505
<SEC-HEADER>0000939767-20-000067.hdr.sgml : 20200505
<ACCEPTANCE-DATETIME>20200505161257
ACCESSION NUMBER:		0000939767-20-000067
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200505
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200505
DATE AS OF CHANGE:		20200505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXELIXIS, INC.
		CENTRAL INDEX KEY:			0000939767
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				043257395
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30235
		FILM NUMBER:		20848968

	BUSINESS ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		6508377000

	MAIL ADDRESS:	
		STREET 1:		1851 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS INC
		DATE OF NAME CHANGE:	20000207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXELIXIS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	20000106
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>exel8-k20200331earning.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:b187725cc7c24b94bebbf96e94e18641,x:400978b4aca44ab9959fc1583402b757-->
<!-- Document created using Wdesk  -->
<!-- Copyright 2020 Workiva -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:schedoi-fednote="http://fasb.org/dis/schedoi-fednote/2019-01-31" xmlns:fs-interest="http://fasb.org/dis/fs-interest/2019-01-31" xmlns:sfp-ibo="http://fasb.org/stm/sfp-ibo/2019-01-31" xmlns:sfp-sbo="http://fasb.org/stm/sfp-sbo/2019-01-31" xmlns:sic-std="http://xbrl.sec.gov/sic-std/2011-01-31" xmlns:stpr-std="http://xbrl.sec.gov/stpr-std-std-std/2018-01-31" xmlns:currency-ent-std="http://xbrl.sec.gov/currency-ent-std/2019-01-31" xmlns:lea="http://fasb.org/dis/lea/2019-01-31" xmlns:ctbl="http://fasb.org/dis/ctbl/2019-01-31" xmlns:guar="http://fasb.org/dis/guar/2019-01-31" xmlns:ru="http://fasb.org/dis/ru/2019-01-31" xmlns:stpr-all="http://xbrl.sec.gov/stpr-all-all-all/2018-01-31" xmlns:leas="http://fasb.org/dis/leas/2019-01-31" xmlns:sfp-clreo="http://fasb.org/stm/sfp-clreo/2019-01-31" xmlns:iaoi="http://fasb.org/dis/iaoi/2019-01-31" xmlns:soi-ins="http://fasb.org/stm/soi-ins/2019-01-31" xmlns:country-ent-std="http://xbrl.sec.gov/country-ent-std/2017-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:fs-insa="http://fasb.org/dis/fs-insa/2019-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:cce="http://fasb.org/dis/cce/2019-01-31" xmlns:inv="http://fasb.org/dis/inv/2019-01-31" xmlns:naics-ent-std="http://xbrl.sec.gov/naics-ent-std/2017-01-31" xmlns:srt-std="http://fasb.org/srt-std/2019-01-31" xmlns:stpr-ent-all="http://xbrl.sec.gov/stpr-ent-all-all-all/2018-01-31" xmlns:stpr-ent-std="http://xbrl.sec.gov/stpr-ent-std-std-std/2018-01-31" xmlns:schedoi-iiaa="http://fasb.org/dis/schedoi-iiaa/2019-01-31" xmlns:us-arcroles="http://fasb.org/us-arcroles/2019-01-31" xmlns:dccpoa="http://fasb.org/dis/dccpoa/2019-01-31" xmlns:soi-sbi="http://fasb.org/stm/soi-sbi/2019-01-31" xmlns:us-gaap-all="http://fasb.org/us-gaap-all/2019-01-31" xmlns:scf-sd="http://fasb.org/stm/scf-sd/2019-01-31" xmlns:ceclcalc3l="http://fasb.org/dis/ceclcalc3l/2019-01-31" xmlns:dei-ent-all="http://xbrl.sec.gov/dei-ent-all/2019-01-31" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:naics-all="http://xbrl.sec.gov/naics-all/2017-01-31" xmlns:re="http://fasb.org/dis/re/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:reorg="http://fasb.org/dis/reorg/2019-01-31" xmlns:invco="http://fasb.org/dis/invco/2019-01-31" xmlns:currency-ent-all="http://xbrl.sec.gov/currency-ent-all/2019-01-31" xmlns:currency-std="http://xbrl.sec.gov/currency-std/2019-01-31" xmlns:currency-ent-dep="http://xbrl.sec.gov/currency-ent-dep/2019-01-31" xmlns:aro="http://fasb.org/dis/aro/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" xmlns:ocpfs="http://fasb.org/dis/ocpfs/2019-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:naics-std="http://xbrl.sec.gov/naics-std/2017-01-31" xmlns:srt-all="http://fasb.org/srt-all/2019-01-31" xmlns:codification-part="http://fasb.org/codification-part/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:deprecated1="http://www.xbrl.org/2009/role/deprecated" xmlns:sec-re="http://fasb.org/dis/sec-re/2019-01-31" xmlns:soi-int="http://fasb.org/stm/soi-int/2019-01-31" xmlns:emjv="http://fasb.org/dis/emjv/2019-01-31" xmlns:sec-suppc="http://fasb.org/dis/sec-suppc/2019-01-31" xmlns:equity="http://fasb.org/dis/equity/2019-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:se="http://fasb.org/dis/se/2019-01-31" xmlns:crcrb="http://fasb.org/dis/crcrb/2019-01-31" xmlns:edco="http://fasb.org/dis/edco/2019-01-31" xmlns:te="http://fasb.org/dis/te/2019-01-31" xmlns:dei-all="http://xbrl.sec.gov/dei-all/2019-01-31" xmlns:fs-bd="http://fasb.org/dis/fs-bd/2019-01-31" xmlns:hco="http://fasb.org/dis/hco/2019-01-31" xmlns:fs-bt="http://fasb.org/dis/fs-bt/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:dr="http://fasb.org/dis/dr/2019-01-31" xmlns:ero="http://fasb.org/dis/ero/2019-01-31" xmlns:country-ent-all="http://xbrl.sec.gov/country-ent-all/2017-01-31" xmlns:schedoi-oocw="http://fasb.org/dis/schedoi-oocw/2019-01-31" xmlns:cecl="http://fasb.org/dis/cecl/2019-01-31" xmlns:rpd="http://fasb.org/dis/rpd/2019-01-31" xmlns:schedoi-sumhold="http://fasb.org/dis/schedoi-sumhold/2019-01-31" xmlns:ceclcalc2="http://fasb.org/dis/ceclcalc2/2019-01-31" xmlns:othliab="http://fasb.org/dis/othliab/2019-01-31" xmlns:soi-egm="http://fasb.org/stm/soi-egm/2019-01-31" xmlns:schedoi-shorthold="http://fasb.org/dis/schedoi-shorthold/2019-01-31" xmlns:soi="http://fasb.org/stm/soi/2019-01-31" xmlns:diha="http://fasb.org/dis/diha/2019-01-31" xmlns:debt="http://fasb.org/dis/debt/2019-01-31" xmlns:schedoi-hold="http://fasb.org/dis/schedoi-hold/2019-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-gaap-ent-std="http://fasb.org/us-gaap-ent-std/2019-01-31" xmlns:bc="http://fasb.org/dis/bc/2019-01-31" xmlns:sic-ent-all="http://xbrl.sec.gov/sic-ent-all/2011-01-31" xmlns:exch-ent-std="http://xbrl.sec.gov/exch-ent-std/2019-01-31" xmlns:rcc="http://fasb.org/dis/rcc/2019-01-31" xmlns:rd="http://fasb.org/dis/rd/2019-01-31" xmlns:sfp-ucreo="http://fasb.org/stm/sfp-ucreo/2019-01-31" xmlns:eui="http://fasb.org/dis/eui/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ap="http://fasb.org/dis/ap/2019-01-31" xmlns:soi-reit="http://fasb.org/stm/soi-reit/2019-01-31" xmlns:fs-mort="http://fasb.org/dis/fs-mort/2019-01-31" xmlns:sec-reins="http://fasb.org/dis/sec-reins/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sec-cndfir="http://fasb.org/dis/sec-cndfir/2019-01-31" xmlns:sr="http://fasb.org/dis/sr/2019-01-31" xmlns:currency-all="http://xbrl.sec.gov/currency-all/2019-01-31" xmlns:scf-dbo="http://fasb.org/stm/scf-dbo/2019-01-31" xmlns:fs-fhlb="http://fasb.org/dis/fs-fhlb/2019-01-31" xmlns:crcpb="http://fasb.org/dis/crcpb/2019-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:scf-inv="http://fasb.org/stm/scf-inv/2019-01-31" xmlns:scf-indira="http://fasb.org/stm/scf-indira/2019-01-31" xmlns:bsoff="http://fasb.org/dis/bsoff/2019-01-31" xmlns:exch-ent-all="http://xbrl.sec.gov/exch-ent-all/2019-01-31" xmlns:oi="http://fasb.org/dis/oi/2019-01-31" xmlns:soi-indira="http://fasb.org/stm/soi-indira/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:schedoi-otsh="http://fasb.org/dis/schedoi-otsh/2019-01-31" xmlns:sfp-dbo="http://fasb.org/stm/sfp-dbo/2019-01-31" xmlns:cc="http://fasb.org/dis/cc/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:crcsbp="http://fasb.org/dis/crcsbp/2019-01-31" xmlns:disops="http://fasb.org/dis/disops/2019-01-31" xmlns:reference="http://www.xbrl.org/2009/role/reference" xmlns:cn-part="http://fasb.org/cn-part/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:srt-roles="http://fasb.org/srt-roles/2019-01-31" xmlns:country-std="http://xbrl.sec.gov/country-std/2017-01-31" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:scf-indir="http://fasb.org/stm/scf-indir/2019-01-31" xmlns:rlnro="http://fasb.org/dis/rlnro/2019-01-31" xmlns:ts="http://fasb.org/dis/ts/2019-01-31" xmlns:us-gaap-std="http://fasb.org/us-gaap-std/2019-01-31" xmlns:naics-ent-all="http://xbrl.sec.gov/naics-ent-all/2017-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:scf-dir="http://fasb.org/stm/scf-dir/2019-01-31" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2019-01-31" xmlns:ni="http://fasb.org/dis/ni/2019-01-31" xmlns:sec-mort="http://fasb.org/dis/sec-mort/2019-01-31" xmlns:fifvd="http://fasb.org/dis/fifvd/2019-01-31" xmlns:otherexp="http://fasb.org/dis/otherexp/2019-01-31" xmlns:scf-re="http://fasb.org/stm/scf-re/2019-01-31" xmlns:sec-vq="http://fasb.org/dis/sec-vq/2019-01-31" xmlns:sec-sum="http://fasb.org/dis/sec-sum/2019-01-31" xmlns:exch-std="http://xbrl.sec.gov/exch-std/2019-01-31" xmlns:ir="http://fasb.org/dis/ir/2019-01-31" xmlns:sheci="http://fasb.org/stm/sheci/2019-01-31" xmlns:foct="http://fasb.org/dis/foct/2019-01-31" xmlns:soc="http://fasb.org/stm/soc/2019-01-31" xmlns:scf-sbo="http://fasb.org/stm/scf-sbo/2019-01-31" xmlns:inctax="http://fasb.org/dis/inctax/2019-01-31" xmlns:ppe="http://fasb.org/dis/ppe/2019-01-31" xmlns:country-all="http://xbrl.sec.gov/country-all/2017-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:con="http://fasb.org/dis/con/2019-01-31" xmlns:sic-ent-std="http://xbrl.sec.gov/sic-ent-std/2011-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:fs-ins="http://fasb.org/dis/fs-ins/2019-01-31" xmlns:eps="http://fasb.org/dis/eps/2019-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:iago="http://fasb.org/dis/iago/2019-01-31" xmlns:pay="http://fasb.org/dis/pay/2019-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:tin-part="http://fasb.org/tin-part/2019-01-31" xmlns:acec="http://fasb.org/dis/acec/2019-01-31" xmlns:us-gaap-entryPoint-all="http://fasb.org/us-gaap-entryPoint-all/2019-01-31" xmlns:nt="http://fasb.org/dis/nt/2019-01-31" xmlns:exel="http://www.exelixis.com/20200505" xmlns:spc="http://fasb.org/stm/spc/2019-01-31" xmlns:exch-all="http://xbrl.sec.gov/exch-all/2019-01-31" xmlns:ides="http://fasb.org/dis/ides/2019-01-31" xmlns:sec-supins="http://fasb.org/dis/sec-supins/2019-01-31" xmlns:sic-all="http://xbrl.sec.gov/sic-all/2011-01-31" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:regop="http://fasb.org/dis/regop/2019-01-31" xmlns:sfp-cls="http://fasb.org/stm/sfp-cls/2019-01-31" xmlns:com="http://fasb.org/stm/com/2019-01-31" xmlns:soi-re="http://fasb.org/stm/soi-re/2019-01-31" xmlns:crcgen="http://fasb.org/dis/crcgen/2019-01-31" xmlns:exch-ent-dep="http://xbrl.sec.gov/exch-ent-dep/2019-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:ei="http://fasb.org/dis/ei/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
	<head>
		<meta http-equiv="Content-Type" content="text/html" />
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="D2020Q1FilingDateFeb25" name="dei:AmendmentFlag" id="Fact-B009F6502E91531CA4034DACC2DAB111-wk-Fact-B009F6502E91531CA4034DACC2DAB111" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric contextRef="D2020Q1FilingDateFeb25" name="dei:EntityCentralIndexKey" id="Fact-357635042E365E458E0FADCD8000162B-wk-Fact-357635042E365E458E0FADCD8000162B">0000939767</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="exel-20200505.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="D2020Q1FilingDateFeb25">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000939767</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2020-02-25</xbrli:startDate>
			<xbrli:endDate>2020-02-25</xbrli:endDate>
		</xbrli:period>
	</xbrli:context></ix:resources></ix:header></div><div><a id="sF7FFC6BEAB725935AD893304DA5A579E"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;">UNITED STATES</span></div><div style="line-height:120%;text-align:center;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:Calibri,sans-serif;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</span></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:266px;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:133px;"></td><td style="width:133px;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:right;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;">FORM </span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-top:2px;text-align:left;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e94-wk-Fact-FAAA2382A52658889BD02246FE081083" name="dei:DocumentType" contextRef="D2020Q1FilingDateFeb25">8-K</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">CURRENT REPORT </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">Date of Report (Date of earliest event reported): </span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><span style="white-space:nowrap"><ix:nonNumeric id="d112073006e108-wk-Fact-0FF9041A61765569BC070A97F3C41505" name="dei:DocumentPeriodEndDate" contextRef="D2020Q1FilingDateFeb25" format="ixt:datemonthdayyearen">May 5, 2020</ix:nonNumeric></span></span></span></div><div style="line-height:120%;text-align:center;font-size:16pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:267px;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:266px;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;"><img src="exellogo18q3a15.jpg" alt="exellogo18q3a15.jpg" style="height:49px;width:148px;"></img></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:2px;text-align:center;font-size:16pt;"><span style="font-family:Calibri,sans-serif;font-size:16pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e127-wk-Fact-D6C83FEFFB365C57A61FB08CE9C7F495" name="dei:EntityRegistrantName" contextRef="D2020Q1FilingDateFeb25">EXELIXIS, INC.</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Exact name of registrant as specified in its charter)</span></div></td></tr></table></div></div><div style="line-height:100%;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e151-wk-Fact-071C00B831325ECA8A8EBB3708996183" name="dei:EntityIncorporationStateCountryCode" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e156-wk-Fact-9954CCAA14955AED823992FE42761175" name="dei:EntityFileNumber" contextRef="D2020Q1FilingDateFeb25">000-30235</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:1px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e161-wk-Fact-D8D70467F6655119B943D18F3702086B" name="dei:EntityTaxIdentificationNumber" contextRef="D2020Q1FilingDateFeb25">04-3257395</ix:nonNumeric></span></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;text-indent:2px;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(State or Other Jurisdiction of Incorporation)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;text-indent:2px;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Commission File Number)</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;text-indent:2px;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(IRS Employer Identification No.)</span></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:12pt;"><span style="font-family:Calibri,sans-serif;font-size:12pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d112073006e183-wk-Fact-914D1D53B56550C19A2F2803EB3949D6" name="dei:EntityAddressAddressLine1" contextRef="D2020Q1FilingDateFeb25"><span style="font-family:Calibri,sans-serif;font-weight:bold;">1851 Harbor Bay Parkway</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span><ix:nonNumeric id="d112073006e189-wk-Fact-B54F1DFAAF13578CAB8A694B3E84A96E" name="dei:EntityAddressCityOrTown" contextRef="D2020Q1FilingDateFeb25"><span style="font-family:Calibri,sans-serif;font-weight:bold;">Alameda</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">, </span><span><ix:nonNumeric id="d112073006e194-wk-Fact-57AC12EEB1545CEC8282C9430C108890" name="dei:EntityAddressStateOrProvince" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:stateprovnameen"><span style="font-family:Calibri,sans-serif;font-weight:bold;">California</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span><span><ix:nonNumeric id="d112073006e199-wk-Fact-65599BF0EC165C3EAE92D3F313092C30" name="dei:EntityAddressPostalZipCode" contextRef="D2020Q1FilingDateFeb25"><span style="font-family:Calibri,sans-serif;font-weight:bold;">94502</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Address of principal executive offices) (Zip Code)</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">(</span><span><ix:nonNumeric id="d112073006e212-wk-Fact-7F1FF692A5D0536685DC3F197B052367" name="dei:CityAreaCode" contextRef="D2020Q1FilingDateFeb25"><span style="font-family:Calibri,sans-serif;font-weight:bold;">650</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">) </span><span><ix:nonNumeric id="d112073006e217-wk-Fact-C032DFA6A5BF54C29FE76F0A86AB6320" name="dei:LocalPhoneNumber" contextRef="D2020Q1FilingDateFeb25"><span style="font-family:Calibri,sans-serif;font-weight:bold;">837-7000</span></ix:nonNumeric></span><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"> </span></div><div style="line-height:120%;text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;">(Registrant&#8217;s telephone number, including area code) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d112073006e229-wk-Fact-29B8AB0A6AD7547BA6568CA8CBC19DFE" name="dei:WrittenCommunications" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d112073006e237-wk-Fact-6BEBD67F9AB0517BB956C54027569CEC" name="dei:SolicitingMaterial" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d112073006e245-wk-Fact-6C64C835E2035C95A6F6356D838093A0" name="dei:PreCommencementTenderOffer" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:24px;font-size:10pt;"><span><ix:nonNumeric id="d112073006e254-wk-Fact-5A693EB7870E5691BA41D4358C13A99D" name="dei:PreCommencementIssuerTenderOffer" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"></span><span style="font-family:Calibri,sans-serif;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="line-height:120%;text-align:left;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.62698412698413%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:39%;"></td><td style="width:21%;"></td><td style="width:40%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;text-decoration:underline;">Title of each class</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;text-decoration:underline;">Trading Symbol(s)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;text-decoration:underline;">Name of each exchange on which registered</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e296-wk-Fact-03D10DAEE4FC5A1EB6C82EF6FB4ED525" name="dei:Security12bTitle" contextRef="D2020Q1FilingDateFeb25">Common Stock $.001 Par Value per Share</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e301-wk-Fact-E4ED733214BA50BB9FA9941AF3B5F022" name="dei:TradingSymbol" contextRef="D2020Q1FilingDateFeb25">EXEL</ix:nonNumeric></span></span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;"><span><ix:nonNumeric id="d112073006e306-wk-Fact-6A5FFF26E9D259DB8BFF3C75B56E35D4" name="dei:SecurityExchangeName" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company</span><span style="font-family:inherit;font-size:10pt;"> </span><span><ix:nonNumeric id="d112073006e315-wk-Fact-A250BB673C8B5212B1E34062AA6F8C67" name="dei:EntityEmergingGrowthCompany" contextRef="D2020Q1FilingDateFeb25" format="ixt-sec:boolballotbox"><span style="font-family:Arial Unicode MS;">&#9744;</span></ix:nonNumeric></span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:Arial Unicode MS;font-size:10pt;">&#9744;</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="s231BB737D4AE547F8803BC1B237787FE"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;-sec-extract:summary;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">Item 2.02.  Results of Operations and Financial Condition.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">On </span><span style="font-family:Calibri,sans-serif;font-size:10pt;">May&#160;5, 2020</span><span style="font-family:Calibri,sans-serif;font-size:10pt;">, Exelixis, Inc. (&#8220;Exelixis&#8221;) issued a press release announcing its financial results for the quarter ended </span><span style="font-family:Calibri,sans-serif;font-size:10pt;">April&#160;3, 2020</span><span style="font-family:Calibri,sans-serif;font-size:10pt;">, and providing a corporate update. A copy of such press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">The information in this report, including the exhibit hereto, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this report and in the accompanying exhibit shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by Exelixis, whether made before or after the date hereof, regardless of any general incorporation language in such filing. </span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">Item 9.01.  Financial Statements and Exhibits.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">(d) &#160;&#160;&#160;&#160;Exhibits.</span></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:30%;"></td><td style="width:1%;"></td><td style="width:58%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;font-weight:bold;">Exhibit Number</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;font-weight:bold;">Exhibit Description</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">99.1</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exel20200331exhibit991.htm"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Press Release issued May 5, 2020.</span></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.INS</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">XBRL Instance Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">The XBRL instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.SCH</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Schema Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.CAL</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.DEF</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.LAB</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Labels Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">101.PRE</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">104</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Cover Page Interactive Data File</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Formatted as Inline XBRL and contained in Exhibit 101.</span></div></td></tr></table></div></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><hr style="page-break-after:always"></hr><div><a id="sA0FFDB540D7A53A19E4DD69FD1DA3316"></a></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div><div><br/></div><div style="line-height:120%;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;font-weight:bold;">SIGNATURES </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="line-height:120%;text-align:right;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;text-align:-moz-right;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:71.42857142857143%;border-collapse:collapse;text-align:left;margin-left:auto;margin-right:0;"><tr><td colspan="4"></td></tr><tr><td style="width:28%;"></td><td style="width:8%;"></td><td style="width:8%;"></td><td style="width:56%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">E</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">XELIXIS, </span><span style="font-family:Calibri,sans-serif;font-size:10pt;">I</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">NC.</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">May&#160;5, 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">/s/ J</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">EFFREY</span><span style="font-family:Calibri,sans-serif;font-size:10pt;">&#160;J. H</span><span style="font-family:Calibri,sans-serif;font-size:8pt;">ESSEKIEL</span></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Date</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:Calibri,sans-serif;font-size:8pt;font-weight:bold;">Jeffrey J. Hessekiel</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">&#160;</span></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;">Executive Vice President and General Counsel</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:Calibri,sans-serif;font-size:10pt;"><br/></span></div><div><br/></div><div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></div>	</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exel20200331exhibit991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sD43D7DF3729D5932B088C5B82F790B04"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.90522243713733%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:29%;"></td><td style="width:37%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:768px;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#ff0000;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:0px;"><img src="exellogo18q3a15.jpg" alt="exellogo18q3a15.jpg" style="height:60px;width:177px;"></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">Contacts:</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Chris Senner</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Chief Financial Officer</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Exelixis, Inc.</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">650-837-7240</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ba6;font-style:italic;text-decoration:underline;">csenner@exelixis.com</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Susan Hubbard</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">EVP, Public Affairs &amp; Investor Relations</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">Exelixis, Inc.</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;">650-837-8194</font></div><div style="line-height:120%;padding-top:0px;text-align:right;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ba6;font-style:italic;text-decoration:underline;">shubbard@exelixis.com</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">ANNOUNCES FIRST QUARTER 2020 FINANCIAL </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">RESULTS AND PROVIDES CORPORATE UPDATE</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">- Total Revenue of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">$226.9</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">&#32;Million, Cabozantinib Franchise Revenue of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">$193.9</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">&#32;Million -</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">- GAAP Diluted EPS of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">$0.15</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">, Non-GAAP Diluted EPS of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">$0.19</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">-</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-style:italic;font-weight:bold;">- Conference Call and Webcast Today at 5:00 PM Eastern Daylight Time -</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">ALAMEDA, Calif. - </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">May&#160;5, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;font-weight:bold;">-</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2020 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and clinical development milestones.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#8220;Exelixis remained productive with strong performance in the first quarter of 202</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">0</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, despite the significant challenges introduced by the COVID-19 pandemic in the U.S. and around the world,&#8221; said Michael M. Morrissey, Ph.D., President and Chief Executive Officer of Exelixis. &#8220;I&#8217;m proud of the commitment demonstrated by our team to help patients with cancer fight their disease in these difficult times, while ensuring the safety of our employees and oncology healthcare professionals. Patient access to our medicines remains a top priority for Exelixis, both on the commercial and investigational fronts.&#8221;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#8220;Recently, we and our partner Bristol Myers Squibb announced positive top-line results from CheckMate -9ER, the pivotal phase 3 study evaluating the combination of nivolumab and cabozantinib in first-line RCC,&#8221; continued Dr. Morrissey. &#8220;The trial met its primary endpoint of progression-free survival, as well as secondary endpoints of overall survival and objective response rate. Together with Bristol Myers Squibb, we are now moving rapidly to submit regulatory applications in the U.S. and European Union in the next few months. We look forward to continuing to provide updates on our other programs and milestones as the year progresses</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">.&#8221;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">First Quarter 2020 Financial Results</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Total revenues </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$226.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$215.5 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Total revenues for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;included net product revenues of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$193.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$179.6 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The increase in net product revenues reflected an increase in the average net selling price and an increase in sales volume.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">2</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Collaboration revenues, comprising license revenues and collaboration services revenues, were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$33.0 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$35.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The decrease in collaboration revenues was primarily related to a decrease in the recognition of milestone related revenues, which was partially offset by higher royalty revenues for the sales of cabozantinib outside of the U.S. generated by Exelixis&#8217;&#160;partner, Ipsen Pharma SAS (Ipsen).</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Research and development expenses</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$101.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$63.3 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The increase in research and development expenses was primarily related to the increases in clinical trial costs and personnel expenses. The increase in clinical trial costs was primarily due to costs associated with the expanding clinical trial program for cabozantinib, which includes COSMIC-312, COSMIC-313 and COSMIC-021. The increase in personnel expenses was primarily due to an increase in headcount to support Exelixis&#8217; expanding discovery and development efforts.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Selling, general and administrative expenses</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;were </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$62.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$60.1 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The increase in selling, general and administrative expenses was primarily related to increases in the Branded Prescription Drug Fee and personnel expenses, which were partially offset by decreases in marketing costs and corporate giving. The increase in personnel expenses was primarily due to an increase in administrative headcount to support Exelixis&#8217; commercial and research and development organizations.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Provision for income taxes </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended March 31, 2020 decreased to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$11.4 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, compared to </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$14.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, primarily due to a decrease in pre-tax income.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">GAAP net income </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;was </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$48.6 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.16</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.15</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, compared to GAAP net income of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$75.8 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.25</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.24</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. The decrease in GAAP net income was primarily related to an increase in research and development expenses, which was partially offset by an increase in net product revenues.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Non-GAAP net income </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;was </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$59.4 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.19</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.19</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, compared to non-GAAP net income of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$85.5 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.28</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, basic and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$0.27</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;per share, diluted, for the comparable period in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">2019</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. Non-GAAP net income excludes stock-based compensation, adjusted for the related income tax effect.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Cash and investments </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">increased $51.8 million during </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">the quarter ended </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">March&#160;31, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">to over </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$1.4 billion</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Non-GAAP Financial Measures</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">To supplement Exelixis&#8217; financial results presented in accordance with U.S. Generally Accepted Accounting Principles (GAAP), Exelixis presents non-GAAP net income (and the related per share measures), which excludes from GAAP net income (and the related per share measures) stock-based compensation expense, adjusted for the related income tax effect for all periods presented. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis believes that the presentation of these non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. In particular, Exelixis believes that these non-GAAP financial measures, when considered together with its financial information prepared in accordance with GAAP, can enhance investors&#8217; and analysts&#8217; ability to meaningfully compare Exelixis&#8217; results from period to period, and to identify operating trends in Exelixis&#8217; business. Exelixis has excluded stock-based compensation expense, adjusted for the related income tax effect, because it is a non-cash item that may vary significantly from period to period as a result of changes not directly or immediately related to the operational performance </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">3</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">for the periods presented. Exelixis also regularly uses these non-GAAP financial measures internally to understand, manage and evaluate its business and to make operating decisions. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. Exelixis encourages investors to carefully consider its results under GAAP, as well as its supplemental non-GAAP financial information and the reconciliation between these presentations, to more fully understand Exelixis&#8217; business. Reconciliations between GAAP and non-GAAP results are presented in the tables of this release.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">2020 Financial Guidance</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis is maintaining the following previously provided financial guidance for fiscal year 2020:</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:31%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Total revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$850 million - $900 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Net product revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$725 million - $775 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Cost of goods sold</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">4% - 5% of net product revenues</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Research and development expenses</font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">$460 million - $500 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Selling, general and administrative expenses</font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$230 million - $250 million</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Effective tax rate</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">20% - 22%</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;">Cash and investments</font><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;">$1.5 billion - $1.6 billion</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Includes $25 million of non-cash stock-based compensation expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Includes $30 million of non-cash stock-based compensation expense.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">This cash guidance does not include any potential new business development activity, which remains a key priority for Exelixis as it continues to build toward becoming a multi-product oncology company.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Cabozantinib Highlights</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Continued Growth in Cabozantinib Franchise Net Product Revenues and Royalties.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;Net product revenues generated by the cabozantinib franchise in the U.S. were&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$193.9 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;during the first quarter of 2020, an increase of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">8.0%</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;year-over-year, with net product revenues of </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$189.2 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;from CABOMETYX and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">$4.7 million</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;from COMETRIQ&#174; (cabozantinib). Based upon cabozantinib-related revenues generated by Exelixis&#8217;&#160;partner Ipsen in the first quarter of 2020, Exelixis earned $17.9 million in royalty revenues.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Further Expansion of Prostate Cancer Cohort in Phase 1b COSMIC-021 Trial of Cabozantinib in Combination with Atezolizumab in Patients with Advanced Solid Tumors. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In January 2020, Exelixis announced plans to further expand an existing metastatic castration-resistant prostate cancer (mCRPC) cohort (Cohort 6) of COSMIC-021, the phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic solid tumors. Cohort 6, which was previously expanded from 30 to 80 patients in July 2019, will now include up to 130 patients.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Presentation of Clinical Results from CheckMate 040 Clinical Trial of the Combination of Cabozantinib and Nivolumab with or without Ipilimumab in Advanced Hepatocellular Carcinoma (HCC). </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In January 2020, Exelixis announced phase 1/2 clinical trial results from the combination of cabozantinib and nivolumab with or without ipilimumab in advanced HCC. Data from the cabozantinib combination cohort of the CheckMate 040 trial were presented on Friday, January 24</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup></font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;at American Society of Clinical Oncology&#8217;s (ASCO) Gastrointestinal Cancers Symposium, which was held in San Francisco, California. These data support Exelixis&#8217; clinical development program of cabozantinib plus immune checkpoint inhibitors in advanced HCC, including the ongoing COSMIC-312 phase 3 pivotal trial of cabozantinib plus atezolizumab versus sorafenib in previously untreated patients.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">4</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Readout of Phase 1b COSMIC-021 Trial mCRPC Cohort at ASCO&#8217;s Genitourinary Cancers Symposium. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In February 2020, Exelixis announced positive efficacy and safety results from an interim analysis of the mCRPC Cohort 6 of COSMIC-021. The data were presented on Thursday, February 13</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup></font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;at ASCO&#8217;s Genitourinary Cancers</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Symposium, which was held in San Francisco, California. Based on regulatory feedback from the U.S. Food and Drug Administration (FDA) and if supported by the clinical data from the recently expanded existing cohort and added mCRPC cohorts from COSMIC-021, Exelixis intends to file with the FDA for accelerated approval in an mCRPC indication as early as 2021.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Enrollment Completion of First 100 Patients in Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Relapsed Radioiodine (RAI)-Refractory Differentiated Thyroid Cancer (DTC). </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In February 2020, Exelixis announced enrollment of the first 100 patients in COSMIC-311, a phase 3 pivotal trial evaluating CABOMETYX versus placebo in patients with RAI-refractory DTC who have progressed after up to two vascular endothelial growth factor receptor-targeted therapies. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Exelixis Partner Takeda Pharmaceutical Company Limited (Takeda) Receives Approval in Japan for CABOMETYX Tablets for the Treatment of Curatively Unresectable or Metastatic Renal Cell Carcinoma (RCC). </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In March 2020, Exelixis announced that Takeda, its partner responsible for the clinical development and commercialization of CABOMETYX in Japan, received approval from the Japanese Ministry of Health, Labour and Welfare to manufacture and market CABOMETYX as a treatment for patients with curatively unresectable or metastatic RCC. Cabozantinib continues to expand its global footprint, where it is currently approved in </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">55</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;countries.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Positive Top-line Results from Pivotal Phase 3 CheckMate </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">-</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">9ER Trial Evaluating Nivolumab in Combination with Cabozantinib in Previously Untreated Advanced RCC.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;In April 2020, Exelixis and Bristol Myers Squibb (BMS) announced that CheckMate </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">-</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">9ER, the pivotal phase 3 trial evaluating nivolumab in combination with cabozantinib compared to sunitinib in previously untreated advanced or metastatic RCC, met its primary endpoint of progression-free survival at final analysis, as well as the secondary endpoints of overall survival at a pre-specified interim analysis, and objective response rate. This preliminary analysis of data showed a favorable safety profile for the combination of a 40 mg dose of cabozantinib with nivolumab, with a low frequency of treatment discontinuations due to adverse events. Detailed results will be submitted for presentation at an upcoming medical conference.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Cabozantinib Data Presentations at the 2020&#160;ASCO&#160;Annual Meeting.&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Cabozantinib will be the subject of 12 presentations at this year&#8217;s meeting, which has adopted a virtual format as a result of the COVID-19 pandemic. Data presentations will include results from </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">non-small cell lung cancer (NSCLC), mCRPC and urothelial carcinoma </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">cohorts of COSMIC-021, as well as updates from other externally sponsored studies.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Corporate Updates</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">COVID-19 Update. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">To date, the COVID-19 pandemic has had a relatively modest impact on Exelixis&#8217; business operations, in particular on Exelixis&#8217; clinical trial and drug discovery activities, and the company is undertaking considerable efforts to mitigate the various problems presented by this crisis. For further details and descriptions of the COVID-19 pandemic&#8217;s actual impact, Exelixis&#8217; mitigation efforts and the risks facing Exelixis if the COVID-19 pandemic continues and grows in severity, please see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;COVID-19 Update&#8221; in Part I, Item 2 and &#8220;Risk Factors&#8221; in Part II, Item 1A of Exelixis&#8217; Quarterly Report on Form 10-Q expected to be filed with the Securities and Exchange Commission on May 5, 2020.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Exelixis Outlines Key Priorities and Anticipated Milestones for 2020-21. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In January 2020, Exelixis announced its key priorities and anticipated milestones for 2020-21, including generating top-line data from ongoing trials </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">5</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">with label-enabling potential, initiating new pivotal trials, and progressing its mid-stage and early pipeline, with up to three new investigational new drug filings in 2020. Subject to the challenges and risks of the Exelixis business, including a modest actual and potential additional impact from the ongoing COVID-19 pandemic, Exelixis is </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">maintaining its guidance for clinical trial enrollment and top-line data timelines for COSMIC-311, COSMIC-312, COSMIC-313, COSMIC-021, EXAMINER and XL092, as well as for the initiation of three phase 3 pivotal trials evaluating cabozantinib in combination with atezolizumab in advanced NSCLC, mCRPC and RCC.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis intends to make appropriate investments to maximize the clinical development opportunities for CABOMETYX, while concurrently working to advance a pipeline of potential new Exelixis medicines through internal drug discovery and business development.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">George A. Scangos, Ph.D. Retires from Exelixis Board of Directors. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">In March 2020, Exelixis announced that George A. Scangos, Ph.D. notified the company of his decision to retire from the Exelixis Board of Directors. Dr. Scangos will not stand for re-election to the Board of Directors at the company&#8217;s 2020 Annual Meeting of Stockholders on May 20, 2020; his resignation from the Board will take effect that same day. Dr. Scangos cited his multiple professional and philanthropic commitments as principal reasons for his decision to retire from the Exelixis Board of Directors.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;">Exelixis Receives Notice of Additional Paragraph IV Certifications. </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Today, May 5, 2020, Exelixis received notice from MSN Pharmaceuticals, Inc. that it had amended its Abbreviated New Drug Application (ANDA), originally filed with the FDA in September 2019, to add two previously-unasserted CABOMETYX Orange Book-listed patents: U.S. Patent No. 7,579,473, the composition of matter patent, and U.S. Patent No. 8,497,284, a method of use patent.&#160;Exelixis is well prepared to respond and will vigorously defend its cabozantinib intellectual property estate.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Basis of Presentation</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis has adopted a 52- or 53-week fiscal year that generally ends on the Friday closest to December 31</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;"><sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup></font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. For convenience, references in this press release as of and for the fiscal periods ended April 3, 2020, January 3, 2020 and March 29, 2019 are indicated as being as of and for the periods ended March 31, 2020, December 31, 2019 and March 31, 2019, respectively. </font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Conference Call and Webcast</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Exelixis management will discuss the company&#8217;s financial results for the first quarter of 2020 and provide a general business update during a conference call beginning at 5:00 p.m. EDT / 2:00 p.m. PDT today, Tuesday, May 5, 2020.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">To access the webcast link, log onto </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">www.exelixis.com</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;and proceed to the News &amp; Events / Event Calendar page under the Investors &amp; Media heading. Please connect to the company&#8217;s website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">855-793-2457</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(domestic) or </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">631-485-4921</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(inte</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">rnational) and provide the conference call passcode </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">8465574 </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">to join by phone.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">A telephone replay will be available until 8:00 p.m. EDT on May 7</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, 2020</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. Access numbers for the telephone re</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">play are: </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">855-859-2056</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(domestic) and </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">404-537-3406</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(inte</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">rnational); the passcode is </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">8465574</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">. A webcast replay will also be archived on </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">www.exelixis.com</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;for one year.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">6</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">About Exelixis</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">Founded in 1994,&#160;Exelixis, Inc.&#160;(Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery and development platform that has served as the foundation for our continued efforts to bring new cancer therapies to patients in need. Our discovery efforts have resulted in four approved products, CABOMETYX&#174; </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">(cabozantinib), COMETRIQ</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#174;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;(cabozantinib), COTELLIC</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#174; </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">(cobimetinib) and MINNEBRO</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#174;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;(esaxerenone), and we have entered into partnerships with leading pharmaceutical companies to bring these important medicines to patients worldwide. Supported by revenues from our marketed products and collaborations, we are committed to prudently reinvesting in our business to maximize the potential of our pipeline. We are supplementing our existing therapeutic assets with targeted business development activities and internal drug discovery - all to deliver the next generation of&#160;Exelixis&#160;medicines and help patients recover stronger and live longer.&#160;Exelixis&#160;is a member of Standard &amp; Poor&#8217;s (S&amp;P) MidCap 400 index, which measures the performance of profitable mid-sized companies. For more information about&#160;Exelixis, please visit&#160;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;text-decoration:underline;">www.exelixis.com</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">, follow </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;">@ExelixisInc</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;on Twitter or like </font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#006ebf;">Exelixis, Inc.</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;on Facebook.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-weight:bold;text-decoration:underline;">Forward-Looking Statements</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">This press release contains forward-looking statements, including, without limitation, statements related to: Exelixis&#8217; plans with BMS to submit regulatory applications for the combination of nivolumab and cabozantinib as a treatment for first-line RCC; Exelixis&#8217; 2020 financial guidance; Exelixis&#8217; plans to further expand Cohort 6 of COSMIC-021; Exelixis&#8217; intention to file with the FDA for accelerated approval of the combination of cabozantinib and atezolizumab in an mCRPC indication, if supported by the clinical data; Exelixis&#8217; and BMS&#8217; plans to submit detailed results from the CheckMate -9ER trial for presentation at an upcoming medical conference; Exelixis&#8217; plans to present data from NSCLC, mCRPC and urothelial carcinoma cohorts of COSMIC-021 at the 2020 ASCO Annual Meeting, as well as updates from other externally sponsored studies; Exelixis&#8217; key priorities and anticipated milestones for 2020-21; Exelixis&#8217; guidance for clinical trial initiation, enrollment and top-line data</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#32;</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">and Exelixis&#8217; plans to reinvest in its business to maximize the potential of the company&#8217;s pipeline, including through targeted business development activities and internal drug discovery. Any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and are based upon Exelixis&#8217; current plans, assumptions, beliefs, expectations, estimates and projections. Forward-looking statements involve risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in the forward-looking statements as a result of these risks and uncertainties, which include, without limitation: the continuing COVID-19 pandemic and its impact on Exelixis&#8217; research and development operations, including Exelixis&#8217; ability to initiate new clinical trials and clinical trial sites, enroll clinical trial patients, conduct trials per protocol, and conduct drug research and discovery operations and related activities; the degree of market acceptance of CABOMETYX and other Exelixis products in the indications for which they are approved and in the territories where they are approved, and Exelixis&#8217; and its partners&#8217; ability to obtain or maintain coverage and reimbursement for these products; the effectiveness of CABOMETYX and other Exelixis products in comparison to competing products; the level of costs associated with Exelixis&#8217; commercialization, research and development, in-licensing or acquisition of product candidates, and other activities; Exelixis&#8217; ability to maintain and scale adequate sales, marketing, market access and product distribution capabilities for its products or to enter into and maintain agreements with third parties to do so; the availability of data at the referenced times; the potential failure of cabozantinib and other&#160;Exelixis&#160;product candidates, both alone and in combination with other therapies, to demonstrate safety and/or efficacy in clinical testing; uncertainties inherent in the drug discovery and product development process; Exelixis&#8217; dependence on its relationships with its collaboration partners, including their pursuit of regulatory approvals for partnered compounds in new indications, their adherence to their obligations under relevant collaboration agreements and the level of their investment in the resources necessary to complete clinical trials or successfully </font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">7</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">commercialize partnered compounds in the territories where they are approved; complexities and the unpredictability of the regulatory review and approval processes in the U.S. and elsewhere; Exelixis&#8217; continuing compliance with applicable legal and regulatory requirements; unexpected concerns that may arise as a result of the occurrence of adverse safety events or additional data analyses of clinical trials evaluating cabozantinib, cobimetinib or esaxerenone; Exelixis&#8217; dependence on third-party vendors for the development, manufacture and supply of its products; Exelixis&#8217; ability to protect its intellectual property rights; market competition, including the potential for competitors to obtain approval for generic versions of Exelixis&#8217; marketed products; changes in economic and business conditions; and other factors discussed under the caption &#8220;Risk Factors&#8221; in Exelixis&#8217; Annual Report on Form 10-K filed with the&#160;Securities and Exchange Commission&#160;(SEC) on&#160;February 25, 2020, and in Exelixis&#8217; future filings with the&#160;SEC, including, without limitation, Exelixis&#8217; Quarterly Report on Form 10-Q expected to be filed with the&#160;SEC&#160;on&#160;May 5, 2020. All forward-looking statements in this press release are based on information available to&#160;Exelixis&#160;as of the date of this press release, and&#160;Exelixis&#160;undertakes no obligation to update or revise any forward-looking statements contained herein, except as required by law</font><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">.</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:174%;padding-top:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;">Exelixis, the Exelixis logo, CABOMETYX, COMETRIQ and COTELLIC are registered U.S. trademarks.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;font-style:italic;">MINNEBRO is a registered Japanese trademark.</font></div><div style="line-height:120%;padding-top:12px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">-see attached financial tables-</font></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><a name="sEC414D73D1B552D684958C06CBE115E8"></a></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">8</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS, INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(in thousands, except per share amounts)</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Net product revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">193,880</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">179,581</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">License revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">20,879</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">25,564</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Collaboration services revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">12,156</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">10,342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">226,915</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">215,487</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Operating expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Cost of goods sold</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">9,289</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">7,501</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">101,877</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">63,289</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">62,940</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">60,138</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">174,106</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">130,928</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">52,809</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">84,559</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">7,220</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">6,087</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">60,035</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">90,671</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">11,423</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">14,896</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;text-indent:24px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">48,612</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">75,775</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Weighted-average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">305,388</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">300,542</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">315,839</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">314,644</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:312px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">&#160;- more - </font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:58%;"></td><td style="width:42%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Exelixis First Quarter 2020 Financial Results</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">Page </font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">9</font><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">&#160;of 9</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">May 5, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS, INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEET DATA</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(in thousands)</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:left;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">March&#160;31, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;text-indent:2px;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">December&#160;31, 2019</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Cash and investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,440,404</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,388,628</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Working capital</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">996,419</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">868,444</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total assets</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,955,604</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,885,670</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Total stockholders&#8217; equity</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,747,652</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">1,685,970</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><a name="sB7E0D22FF8CA5C399B6C9FE0F4D7508A"></a></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">EXELIXIS, INC.</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;font-weight:bold;">RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME </font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(in thousands, except per share amounts)</font></div><div style="line-height:120%;padding-top:0px;text-align:center;text-indent:0px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(unaudited)</font></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:61%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Calibri,sans-serif;font-size:10pt;color:#000000;font-style:normal;font-weight:bold;text-decoration:none;">2019</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">GAAP net income</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">48,612</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">75,775</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Adjustments:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Stock-based compensation - research and development expenses </font><font style="font-family:Calibri,sans-serif;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">5,086</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">4,306</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Stock-based compensation - selling, general and administrative expenses </font><font style="font-family:Calibri,sans-serif;font-size:11pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">8,896</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">8,223</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Income tax effect of the above adjustments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(3,180</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">(2,809</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Non-GAAP net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">59,414</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">85,495</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">GAAP net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.16</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.25</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Non-GAAP net income per share:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.28</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.19</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">0.27</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Weighted-average common shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">305,388</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">300,542</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">315,839</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;">314,644</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:0px;padding-top:0px;text-align:justify;padding-left:0px;text-indent:48px;font-size:11pt;"><font style="font-family:Calibri,sans-serif;font-size:11pt;color:#000000;"></font><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">____________________</font></div><table cellpadding="0" cellspacing="0" style="padding-top:0px;padding-bottom:0px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9pt;padding-left:24px;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">Non-cash stock-based compensation expense used for GAAP reporting in accordance with Accounting Standards Codification Topic 718, </font><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;font-style:italic;">Compensation&#8212;Stock Compensation</font><font style="font-family:Calibri,sans-serif;font-size:9pt;color:#000000;">.</font></div></td></tr></table><div><br></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>exel-20200505.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.exelixis.com/20200505" xmlns:exel="http://www.exelixis.com/20200505" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2019-01-31" schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2018-01-31" schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200505_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200505_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200505_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="exel-20200505_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="CoverPage" roleURI="http://www.exelixis.com/role/CoverPage">
        <link:definition>0001000 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>exel-20200505_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:href="exel-20200505.xsd#CoverPage" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>exel-20200505_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:href="exel-20200505.xsd#CoverPage" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>exel-20200505_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4_label_en-US" xlink:label="lab_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="lab_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30_terseLabel_en-US" xlink:label="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30_label_en-US" xlink:label="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:to="lab_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92_label_en-US" xlink:label="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:to="lab_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:to="lab_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502_label_en-US" xlink:label="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:to="lab_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:to="lab_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:type="arc" />
    <link:label id="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:to="lab_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:type="arc" />
    <link:label id="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2_label_en-US" xlink:label="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:to="lab_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:type="arc" />
    <link:label id="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8_label_en-US" xlink:label="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:to="lab_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:type="arc" />
    <link:label id="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC_label_en-US" xlink:label="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:to="lab_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:type="arc" />
    <link:label id="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0_label_en-US" xlink:label="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:to="lab_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:type="arc" />
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:to="lab_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:type="arc" />
    <link:label id="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:to="lab_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:to="lab_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:to="lab_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:to="lab_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:type="arc" />
    <link:label id="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:to="lab_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:type="arc" />
    <link:label id="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D_label_en-US" xlink:label="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:to="lab_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:type="arc" />
    <link:label id="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7_label_en-US" xlink:label="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:to="lab_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:type="arc" />
    <link:label id="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0_label_en-US" xlink:label="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:to="lab_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:type="arc" />
    <link:label id="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1_label_en-US" xlink:label="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:to="lab_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:to="lab_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:type="arc" />
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:to="lab_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>exel-20200505_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.exelixis.com/role/CoverPage" xlink:href="exel-20200505.xsd#CoverPage" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.exelixis.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:type="locator" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_DocumentType_02C7C1BCB0B6BAB97C43E10A23F57B30" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_AmendmentFlag_35F0153C70AFABF5664CE10A23F51A92" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_DocumentPeriodEndDate_F85076C8426415820CACE10A23F6D131" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityRegistrantName_89A85AD5D720C643C677E10A23F6B502" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityCentralIndexKey_A5192BC07D18E325D17AE10A23F62625" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityEmergingGrowthCompany_D00400593A151204D459E10A23F6C57A" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:label="loc_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_Security12bTitle_E3B6733ED7F2B5D758B7E10A23F620F2" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:label="loc_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_TradingSymbol_DE94E96A62AB3D55BF68E10A23F7FDF8" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_SecurityExchangeName_539585D5556CA0248ADFE10A23F720AC" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityFileNumber_7E0259E86F74B78B079CE10A23F783A0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8BEDA67D88BA321CE607E10A23F70107" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityTaxIdentificationNumber_D214D328EEDB0BE065F0E10A23F78761" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityAddressAddressLine1_D3E5FA9E18591F96B32BE10A23F8E115" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityAddressCityOrTown_F37D9C7F95D0D190A716E10A23F8B1C5" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityAddressStateOrProvince_DE4E3B8A76B4139F0C85E10A23F88174" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_EntityAddressPostalZipCode_BBEFFCA3B3E004C75360E10A23F88F34" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:label="loc_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_CityAreaCode_980E4A4351073C3A1BFBE10A23F8521D" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_LocalPhoneNumber_BB4EA1639AF6841666BFE10A23F8E4E7" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_WrittenCommunications_0D22EF01AF040B6B074AE10A23F9F3B0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_SolicitingMaterial_3670C24B45C277CD52CFE10A23F94AB1" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_PreCommencementTenderOffer_CE3353C18BCE8E8C2EB4E10A23F9D8A0" xlink:type="arc" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_99522D57C04239D831E3E10A23F593D4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_75254E6404D9422FF900E10A23F97DAE" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>exellogo18q3a15.jpg
<TEXT>
begin 644 exellogo18q3a15.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M                ]M8  0    #3+4A0("
M                                     !%C<')T   !4    #-D97-C
M   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G
M6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q
M (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $
M#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#
M   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A
M8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M             !)S4D="($E%0S8Q.38V+3(N,0
M                                            6%E:(        /-1
M  $    !%LQ865H@                     %A96B        !OH@  ./4
M  .06%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E
M<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%
M0R!H='1P.B\O=W=W+FEE8RYC:
M                          !D97-C         "Y)14,@-C$Y-C8M,BXQ
M($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)
M14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                            9&5S8P         L4F5F97)E;F-E(%9I
M97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E
M9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                             '9I97<      !.D_@ 47RX $,\4  /M
MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                         H\    "<VEG(     !#4E0@8W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$
M P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0
M 0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E
M\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W
M>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'
MR,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]
M_**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*.(L5GN:5LUQC]^K)NW1+:,5Y15DO)!1117K'@A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY2I[]%'7\:^/:*_%,P\3N(\7*[Q#@NT$HI?-+F^]L_I;*/!'@W 045@U4?\
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M5D?Y@YACZ^-Q-3&8J7-4J2<I-]6W=O[PHHHKH.,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHKE?C?X\_X57\&O%?B4;=V@Z1=7Z
M]&>.)F4?BP _&LJ]:%&G*K4VBFWZ+5F^%P]3$5H8>DKRDTEZMV7XGY&?\%+?
MCW)\>?VL?$$D4YDTGPW(=$T]0?E"PL1(X['?+YC9[KM]!7@%23SR74[R2,TD
MDC%G=CN9B>22>^:CK^",VS&KC\95QM;XJDG)_-[>BV7D?ZMY#D]#*<MH9;AE
M[E*,8KSLK7]6]7YL****\\]8**** "BBB@ HHHH **** /NS_@B)\>I-"^(W
MB#X=WD_^AZ] =4T]&/"7,0 D51ZO%AC[0#\?TPK\*_V/OB&WPK_:C\!ZZ)/*
MCL]:MTN&':"1Q%+_ .0W>OW4K^K/!?-Y8K)982H[NC*R_P ,M5^/-\C^#?I)
M</PP/$D,PI*RQ$$W_CA[K_\ )>5OSNPHHHK]@/YY"BBB@ HHHH **** "BBB
M@ K@OVD/VA=!_9A^$^H>*_$$O[BU'EVULKA9;^X(.R&/_:;!.?X5#,> :ZGQ
MEXRTOX>^%-0US6KR'3])TN!KFZN)3A8D49)]_8#DD@#).*_&7]NG]L?5/VP?
MBS)?_OK3PQI)>#1;!C_JHR>97'3S9, MCH JY.W)^ \0.-J608+]W9UYW4%V
M[R?DOQ>FUVOUCPE\,Z_%F9_O;QPM)IU)=^T(O^:75_96N]D^#^/GQTU[]H[X
MI:EXK\17'F7VH-A(D)\JTB'W(8P>B*#]222<DDGC:**_CC$8BKB*LJU:3E*3
M;;>[;W;/]&,'@Z.$H0PV&BHP@E&*6B26B2]$=9\#O@_JGQ\^+.A>$=&7-]K=
MTL DV[EMX_O22L/[J(&8^RFOW/\ A9\-=*^#GPYT;POHL/V?2]#M4M8%/WF
MZLQ[LS$L3W+$U\>?\$9?V5/^$)\ 7?Q,U>WVZIXF1K725=>8+)6&Z3D<&5UX
M_P!B-2.'-?<E?U1X1<*_V=EO]HUU^]KV:\H?97_;WQ/RY>Q_"?TA.._[7SG^
MQ\+*]#"MIVVE4VD_^W?A79\W1A1117Z\?SV%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0H YK^AO ?FOC>W[O[_?/Y%^E5R6RQ?:_??=^Z+%%%%?T,?R"%%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \&_
MX*'?LGK^U?\  .ZL;&-#XGT(M?Z,Y.-\@7#P$^DBC'8;@A/ K\8M0T^?2;Z>
MUNH9;>ZMI&BFBD4J\3J<,K \@@@@@]"*_H6KX1_X*@_\$X9OB'+??$GP'9^9
MKB)YNM:5"OS:B!UN(@.LP'WD'WP,CY\A_P 1\6.!*F/A_;& C>I%6G%;RBMF
MN[CVZK;:S_ISP"\4Z655/]7LVGRT:CO3D]H3>\6^D9/5/92O?23:_-&BG$;3
M@C:5ZBFU_,)_;@4444 %%%% !1110 5U'P8^$.M?'CXF:/X4T"W-QJ6L3B).
M#LA7J\KGLB*"Q/H#UXK)\)>$M4\>>)+/1]%L+K5-4U"016UK;1F269CV 'MD
M^P!/:OUX_P""=W["%I^R+X&;4M76WN_'6N0A=0N$(=;&+.X6T3>@(!<C[S =
M0JU]QP+P9B,_QJA9JC%ISEY?RK^\^G9:]#\Q\4?$C"<)Y8ZEU+$S35.'=_S2
M7\L>O=^ZM7=>R? KX.Z7\ ?A)H?A#1U_T'1+80B0C#7$A):25A_>=RS'W:NN
MHHK^SL/AZ="E&C15HQ222V22LE\D?YNXO%5L57GB<1)RG-N4F]VV[MOS;U"B
MBBMCG"BBB@ HHJ&\O(=,LYKBXFBM[>W1I)99'"I$@&2S$\  #))XQ2;MJQI-
MNR,7XG_$W1?@YX"U3Q-XBO8]/T?2(3//*_7T"J/XF8D*JCEF( ZU^+/[8/[5
MNM?M<?%NY\0:ENM=-M\P:3IP;*6%OG@>[MP7;N>F%"@>E?\ !2?]NV;]J?Q]
M_8>@W$B> ]!F/V0 %?[3G&0;EQUVX)"*>BDG@L0/E^OY2\4./GFU?^SL%+_9
MX/5K[<EU_P *^SWW[6_O/P.\*5D&%6<9G#_:ZJT3_P"74'T\IR^UV7N_S7**
M**_(3^A K[$_X(_?LJGXN_&23QUJMNSZ!X)D5[;>OR7.H$;HP/7RAB0]PQB[
M&OD[P;X0U#Q_XMTW0])MVN]3UBYCL[6%>LDCL%4>W)'/05^Y/[,/P#T_]FCX
M(Z'X/T_RY#IT.Z[N%7!O+EOFEE/?EB<9Y"A1V%?JWA/PK_:>:?7*ZO2H6;[.
M7V5\OB?HD]S\'\?.//[#R/\ L["RM7Q5XJV\8?;EY7ORKU;7PGH%%%%?UL?Y
M_A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_16OB9_X5-]_P#':/\ AM;XR?\ 16OB9_X5-]_\=KS+YO:CYO:BR"[/3?\
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M5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':/^&UOC)_T5KXF?\
MA4WW_P =KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?\ A4WW_P =H_X;6^,G_16O
MB9_X5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':/^&UOC)_T5KX
MF?\ A4WW_P =KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?\ A4WW_P =H_X;6^,G
M_16OB9_X5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':/^&UOC)_
MT5KXF?\ A4WW_P =KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?\ A4WW_P =H_X;
M6^,G_16OB9_X5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':/^&U
MOC)_T5KXF?\ A4WW_P =KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?\ A4WW_P =
MH_X;6^,G_16OB9_X5-]_\=KS+YO:CYO:BR"[/3?^&UOC)_T5KXF?^%3??_':
M/^&UOC)_T5KXF?\ A4WW_P =KS+YO:CYO:BR"[/?_P!G/]L'XMZY^T)X#LKW
MXI?$:\L[SQ%I\$\$_B2\DBGC:YC5D93(0RD$@@C!!K]YJ_G4_9>_Y.5^'?\
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M5E9205((()!K]UJ_GG_8I_Y/(^$O_8Y:/_Z70U_0Q6-3<TAL%%%%9EA1110
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M66\G^2Z)+HE9):)!1117<>6%%%% !1110 5^<?\ P5H_;Y_MBYO/A3X-OO\
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M5.S/V:HHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV_:@^("^-?%5GN\ ^&;@8AE7Y=:NUPPAP>#$G!D['(3G+$?LJB+$BJJA548
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MKF/F]JZ?X*_\EC\)?]AFS_\ 1Z4@/Z/J***Y3H"BBB@ HHHH **** "BBB@
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MYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:OVC_X(E_
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MF]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J
M#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]JU? W@;6/B9XOT
M[P_X?TZZU;6=6F6WM+2W3=),Y[#VZDDX  ). ":0'UG_ ,$0O@'-\4_VPHO$
MTT!?2? -H]_(Y'R&YE5H8$_WN9)!_P!<?P/[.UX;_P $^?V.K3]BW]GNQ\.L
MT-UXAU!OM^N7<?W9KIE V(3SY<:@(O3."V 6(KW*N>4KLVBK(****DH****
M"BBB@#A?VH/^3:?B)_V+.I?^DLM?SJ?-[5_17^U!_P FT_$3_L6=2_\ 266O
MYU/F]JVI&=0/F]J/F]J/F]J/F]JU,P^;VH^;VH^;VH^;VH /F]J/F]J/F]J/
MF]J /3?V*?\ D\CX2_\ 8Y:/_P"ET-?T,5_//^Q3_P GD?"7_L<M'_\ 2Z&O
MZ&*PJ;FM/8****S+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M^9?^"Q7_ "CC^(W_ '#?_3G:5]-5\R_\%BO^4<?Q&_[AO_ISM*J.Z _#3YO:
MCYO:CYO:CYO:NDYP^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:NG^"O_
M "6/PE_V&;/_ -'I7,?-[5T_P5_Y+'X2_P"PS9_^CTI ?T?4445RG0%%%% !
M1110 5S'QA^%&D?'#X8ZUX3UR$S:7K=N;>7;]Z(]4D7T9&"L#ZJ*Z>BLZU&%
M:G*E55XR333V:>C3]3;#8FKAZT<10DXSBTTUNFG=->:>I^"/QV^#6K_L^_%G
M6O".MIMOM'G,?F*,)<1D;HY5_P!ET*L/3.#R#7(U^JW_  5T_9"_X7)\*1X[
MT2U\SQ)X/@8W*1KE[ZP!+./=HLM(/]DR#DD"ORIK^)^..%ZF19I/"Z^SE[T'
MWB^GJMG]^S1_I=X8<=4N*<CIX[15H^[4CVFEJTNTOB7K;=,****^//T0****
M "BBB@ K[ _X)(?M??\ "E/BO_P@^M77E^&?&4ZK TC82ROSA4?V63 C;W$9
MX -?'].1VC<,I*LIR"#R#7L9!G6(RG'T\?AOB@]NC75/R:T_X)\[Q7PUA,_R
MJME.-7NU%:_6+WC)><79^>ST9_0U17S;_P $S?VO1^U!\#8[35+GS/%_A54L
M]3W'Y[M,$17/_ P"&_VU8\ @5])5_<63YKA\RP=/'85WA-77EW3\T]'YH_S"
MXAR'%Y+F-;*\=&U2E)I]GV:\I*S7DT%%%%>D>,%%%% !1110 4444 %%%% !
M1110 4444 %4M?U^Q\*:'>:GJ5U;V.GV$+3W%S.X2."-1EF8G@  5=K\O_\
M@JQ^WY_PM?6KCX;^#[[=X8TR;;J]Y"WRZI<(?]6I'WH8V'7H[C(R%4GY7B_B
MK#9#@'BZ^LGI"/64O\ENWT7G9/[KP]X$QO%6:QR_#>[!:U)VTA'J_5[175^2
M;7DW_!0;]MN^_:]^)NRRDFMO!>ANT>DVA!4SGHUS(/\ GHXZ _<7 X)8M\^4
M45_%N:YIB<QQ4\;BY<TYN[?Z+LDM$NB/]*,AR/!Y/@*66Y?#EI4U9+\VWU;>
MK?5ML****\\]8***^C/^"9G[*O\ PTS^T+;2ZC;^;X6\*;-1U3>N8[AMW[FW
M/_71E)([HC]\5Z64977S+&4\#AE>=1I+]6_)+5^2/'X@SS"Y-EM;-,8[4Z47
M)^?9+SD[)>;1]W?\$K/V5?\ AGO]G^+6=4M_+\4>-%CO[H.N'MK?!,$/J#M8
MNPZAG(/W17U%117]S9+E-#+,#3P&'^&"MZ]V_-N[?FS_ "[XDX@Q6=YG6S7&
M/WZLFWV2V45Y15DO)!1117J'AA1110 4444 %?,O_!8K_E''\1O^X;_Z<[2O
MIJOF7_@L5_RCC^(W_<-_].=I51W0'X:?-[4?-[4?-[4?-[5TG.'S>U'S>U'S
M>U'S>U !\WM1\WM1\WM1\WM0 ?-[5T_P5_Y+'X2_[#-G_P"CTKF/F]JZ?X*_
M\EC\)?\ 89L__1Z4@/Z/J***Y3H"BBB@ HHHH **** "J^K:K:Z#I5S?7UQ#
M9V=G$T]Q/,X2."-069V8\!0 22> !5BOSE_X+G?MM2>%M#@^#OAV[\N]U:);
MOQ'+&?FBMR08K;/8R8WL.#M"#D.13BKNPF[(^4O^"FW_  4!OOVS_BJUEI,]
MQ;_#_P /3,FDVIRGVU_NM>2K_>;D*",HAQP6?/S#\WM1\WM1\WM72E96,-P^
M;VH^;VH^;VH^;VI@'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?
M-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4
M'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U
M'S>U'S>U !\WM4NG:C<:3J$-W:3S6MU:R+-#-"Y22)U.596'(8$ @CD$9J+Y
MO:K.AZ)>>)M:M-.T^UFO+^_F2WM[>%"\D\CD*J*!R220 /4T ?K1_P $D/\
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M"OA'2X=)T?3Q\L:?,\SG[TDCGEY&QRQY.!V  ZRBBLS0**** "BBB@ HHHH
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MQ#:V=G$T\\\SA(X8U!+,S'@* "23P *_$/\ X*@_M]W7[9OQ:-CH\\T/P_\
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M[DRV/RZ^;VH^;VH^;VH^;VKI,0^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J
M#YO:CYO:CYO:OT"_X(5?L_>!_CJ?BE_PF7A70O$W]E_V3]C_ +1M$N/LWF?;
M=^S<#C=L3..NT>E*3LKC2N?G[\WM1\WM7] O_#O[X(_]$K\"_P#@HB_PH_X=
M_?!'_HE?@7_P41?X5G[5%^S9_/U\WM1\WM7] O\ P[^^"/\ T2OP+_X*(O\
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M_P#T>E<Q\WM73_!7_DL?A+_L,V?_ */2D!_1]1117*= 4444 %%%% !1110
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M1YG5A[P&OR>^;VK:G'2YE-ZV#YO:CYO:CYO:CYO:M2 ^;VH^;VH^;VH^;VH
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M* "BBB@#^?G_ (*!_P#)[GQ5_P"QFOO_ $:U>0?-[5Z__P % _\ D]SXJ_\
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MH#GCY4\Z3\I)I!_P&OE+YO:NW_:;\7GX@?M'>/M<,GF#5O$5_=J<Y&U[B1E
MZ\ $ >PKB/F]JZH[&#W#YO:CYO:CYO:CYO:F(/F]J/F]J/F]J/F]J #YO:CY
MO:CYO:CYO:@#[)_X(Y?L.V?[3WQANO%7B:U6Z\'^"7CD-M(,QZE>M\T43#^*
M- "[CO\ (I!5FK]G%4(N!P!T'I7S7_P2/^%T/PO_ &#/!02-4NO$,<NMW;C_
M ):O/(2A/TA6%?\ @-?2E<TI79M%604445)04444 %%%% !1110 4444 >7_
M +1_[&_PY_:NT7[+XU\-V>H7,:;+?48AY-_:?[DR_-@'G:<H3U4U^<?[2_\
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ML%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\G_ &S/V2M!_;*^"5]X3UC;;W8_TC2M1";I--N@#MD'
MJIY5E_B5CT."/6** /YO_C!\(]>^!'Q*U?PGXFLFT_6M%G,%Q$>5/=70_P 2
M,I#*W0J0>]<U\WM7[3_\%8?^">Z?M:?#3_A)_#-JO_"PO"\#&W5!SK%L,LUJ
M?]L'+1G^\2O ?*_BU<6\EI<20S1O#-$Q1T<;61AP01V(KIC*Z,91L-^;VH^;
MVH^;VH^;VJB0^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:OU9_X(P_\
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MK_R6/PE_V&;/_P!'I7,?-[5T_P %?^2Q^$O^PS9_^CTI ?T?4445RG0%%%%
M!1110 4444 ?S.W5S)>W4DTK&269B[L>K,3DDTSYO:G7%O):7$D4BM')&Q1U
M88*D<$&F_-[5UG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-
M[4?-[4 ?O[_P3LU^U\2_L-?"VXLS&88_#UM:MY9./,A7R9.YYWQMGWSTZ#VB
MOR]_X(=?MSZ;X6@F^#OBB]CLUO+IKOPU<SOMC:60CS+/)X4LWSH/XF:09W%
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ML%%%%24%%%% !1110 4444 %%%% !1110 5^;_\ P<0_\B9\+?\ K\U'_P!
MMZ_2"OS?_P"#B'_D3/A;_P!?FH_^@6]5'<F6Q^77S>U'S>U'S>U'S>U=)B'S
M>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0 ?-[5^F?_!NGT^,7_<%_]R%?F9\W
MM7Z9_P#!NGT^,7_<%_\ <A45/A*CN?IE1117.;!1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX9_\#9_\*/\ B(7\9?\ 1._#/_@;/_A1R,.9'ZM45^4O_$0OXR_Z)WX9_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M% !1110 4444 %?,O_!8K_E''\1O^X;_ .G.TKZ:KYE_X+%?\HX_B-_W#?\
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M_K,_@,**** "BBB@ HHHH **** "BBB@ HHHH *^9?\ @L5_RCC^(W_<-_\
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M?L1?#W0[J-H;Y]-_M&Y1AATDNI'N2K?[2B4+[;<5E4V+I[GN-%%%8FH4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !63X\\"Z3\3?!FJ>']>L8=2
MT?6+=[6[MI1E9HV&"/4'N",$$ C! -:U>0_ML?M>Z'^QA\$;[Q1JGEW6I2YM
MM'TW?M?4;H@E5]0B_>=NRCNQ4$ _%W]O3]DR;]C3]HG4O"/VZ/4=-DC6_P!+
MG\Q3,UI(6""51]V12K*> &V[@ & KQKYO:N@^*WQ2USXU_$35O%7B2^DU+6M
M:N#<7,S^IX"J/X550%51PJJ .E<_\WM74CG#YO:CYO:CYO:CYO:F ?-[4?-[
M4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM3[6W:\N8X4V[Y6"+N8*N2<#). ![D
M@"F?-[4?-[4 ?NW_ ,$W_P!AO3/V+?@I##)]EO?&'B!$NM;U"+#*6QE;>)N\
M4>3@_P 3%FXR /HJOSK_ ."+W_!1#_A-=)M?@_XTOLZQI\6WPU>S/S>P*,FT
M8G_EI&H)0_Q("O!0;OT4KFE>^IM';0****DH**** "BBB@ HHHH **** "BB
MB@ HHHH **** "OS?_X.(?\ D3/A;_U^:C_Z!;U^D%?F_P#\'$/_ ")GPM_Z
M_-1_] MZJ.Y,MC\NOF]J/F]J/F]J/F]JZ3$/F]J/F]J/F]J/F]J #YO:CYO:
MCYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:
M@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;
MVH^;VH^;VH /F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@#[3_P""#O\ R>Y=
M_P#8LWG_ *-MZ_9*ORS_ .#>WX4SW?Q!\?>.)(RMK8:?%H<$A'$KS2":0#W4
M019_ZZ+ZFOU,KGJ;FT-@HHHJ"@HHHH **** "BBB@#A?VH/^3:?B)_V+.I?^
MDLM?SJ?-[5_17^U!_P FT_$3_L6=2_\ 266OYU/F]JVI&=0/F]J/F]J/F]J/
MF]JU,P^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J /3?V*?\ D\CX2_\ 8Y:/
M_P"ET-?T,5_//^Q3_P GD?"7_L<M'_\ 2Z&OZ&*PJ;FM/8****S+"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *^9?^"Q7_ "CC^(W_ '#?_3G:
M5]-5\R_\%BO^4<?Q&_[AO_ISM*J.Z _#3YO:CYO:CYO:CYO:NDYP^;VH^;VH
M^;VH^;VH /F]J/F]J/F]J/F]J #YO:NG^"O_ "6/PE_V&;/_ -'I7,?-[5T_
MP5_Y+'X2_P"PS9_^CTI ?T?4445RG0%%%% !1110 4444 %%%% !1110 444
M4 %%%% 'RK_P5<_91M_CQ\!KCQ-8I#'XD\#P2WT<C$+]IM -T\).>P7>N>ZD
M#&\FOR-K]-/^"SG[59\&^!;/X8Z/<;=2\1*+O5V1OF@LU;Y(CZ&5UR><[8R"
M"'K\RZ_D?Q@KX&IG[6$7OQBE4:V<NGS4;)OY;IW_ - OH[X7-*/"D98]_NY3
MDZ2>ZAU^3ES.*MMK=IJQ1117Y6?NP4444 %%%% !1110 4444 %%%% !1110
M 4444 ?H%_P1*_9QL]5OM;^)VH-;7%QILK:1I4(=6:VD9%::9AU5BCJB].'D
MXP0:_1JOQO\ ^":O[7K?LL_'**'5+CR_"'B@I9:J&/R6C9Q%=?\ ;,DAO]AG
MX)"U^QT<@E565@RL,@CO7]<>#^/P-;(8X?"KEG3;YUU<GJI>C6B[6MT/\_?I
M#97F>'XJEB\<^:G5BO9/HHQ23AZQ=V^_,I:<UAU%%%?JA^$A1110 4444 %%
M%% !1110 4444 %%%% !7S+_ ,%BO^4<?Q&_[AO_ *<[2OIJOF7_ (+%?\HX
M_B-_W#?_ $YVE5'= ?AI\WM1\WM1\WM1\WM72<X?-[4?-[4?-[4?-[4 'S>U
M'S>U'S>U'S>U !\WM73_  5_Y+'X2_[#-G_Z/2N8^;VKI_@K_P EC\)?]AFS
M_P#1Z4@/Z/J***Y3H"BBB@ HHHH **** "BBB@#)\<^!M'^)OA#4- U_3[75
MM&U:%K>[M+A-T<R'J".Q'!!'((!!! -?C[_P44_X)*^(/V7[N]\6>"8;SQ%\
M/F+2RA09+S0AG.V4#EX0.DHZ '?MP&;]F*&4.N#R#U'K51DT3*-S^9KYO:CY
MO:OU]_;=_P""*7A7XVSWGB+X;R6?@OQ-)NEET\H1I-^_7[JC-NQ]4!3C[@)+
M5^7/QU_9O\;_ +-/BQM%\;>'=0T.[R?)>5-UO=@=6BE7*2+[J3CH<'BMHR3,
MW%HXCYO:CYO:CYO:CYO:K)#YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]
MJ/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J/F]J/F]
MJ/F]J #YO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH /F]J]C_ &/_ -N3QS^Q
M?XR^W^&;[[1I-RX.HZ+=,6LK]?4K_!(!TD7!'?<N5/CGS>U'S>U+<#^@;]CO
M]M3P=^VG\/?[9\,W#6^H6>U-4TBX8?:M-D.<!AT9&P=LB\, >C!E'K]?SD?
MOXZ>)OV<?B9IWBSPGJ,FFZQIK<'[T=Q&?O12KT>-@,%3[$8(!'[G_L.?MH^'
M_P!M?X/PZ_I?EV6M6.V#6M*+[I-/G(SQW:-\$H_<9!PRL!C.%C:,KGM%%%%9
ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(:?:W5JTGA'P[)'J.O2L/W;Q*V4M\_WIF7;CKM#L/NU^[JJ$7 X Z#TKS?\
M99_9<\+?LB_":S\)^%;8K!$?.O+N4 W&HW! #32GNQP  .%  ' KTBN>4KLV
MC&P4445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%#,$7)X ZGTH
M P_B7\2-%^$'@+5O$_B*^ATW1-%MVNKNYDZ(@[ =68G"JHR68@ $D"OP;_;E
M_;'UK]M3XVW7B2^\ZST:US;:+IK/E;"VSQG'!D? 9V'4X'W54#VS_@KK_P %
M#?\ AIKQ\W@?PG?;_ 7ANY/F3PME-;NURIER/O0IR$[-R_.5Q\7?-[5M3C;5
MF4I7T#YO:CYO:CYO:CYO:M2 ^;VH^;VH^;VH^;VH /F]J/F]J/F]J/F]J #Y
MO:CYO:CYO:CYO:@ ^;VH^;VH^;VH^;VH LZ'K=YX9UJTU'3[J:SO["9+BWN(
M7*202(0RNI'(((!!]17[C?\ !,[]O2S_ &U/@\J:C)!;^//#J+#K5H,+]H'1
M+N-?[CX^8#[CY'0H6_##YO:NY_9P_:$\1?LO?%[2?&7AFX\G4--?$D+$^3>P
MG'F02 =48?B" 1@@$1*-T5&5C^BRBN!_9E_:.\._M5_!O2?&?AN;=9Z@NR>W
M=@9M/N%QYD$H'1U)'LRE6&58$]]7.;!1110 4444 %%%% !1110 4444 %%%
M% !1110 5^;_ /P<0_\ (F?"W_K\U'_T"WK](*_-_P#X.(?^1,^%O_7YJ/\
MZ!;U4=R9;'Y=?-[4?-[4?-[4?-[5TF(?-[4?-[4?-[4?-[4 'S>U'S>U'S>U
M'S>U !\WM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\W
MM1\WM1\WM1\WM0 ?-[4?-[4?-[4?-[4 'S>U'S>U'S>U'S>U !\WM1\WM1\W
MM1\WM0 ?-[4?-[4?-[4?-[4 'S>U7?#'AG4/&GB.QTC2;.?4-3U*=+:UMH5W
M23RN0JJH]22*L^!? 6M?$[Q59Z'X=TN^UK5]0<1V]I9PF660^P'8=23P!R<
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MVH^;VH^;VH /F]JZ?X*_\EC\)?\ 89L__1Z5S'S>U=/\%?\ DL?A+_L,V?\
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M_NRC_B'3_P"JQ?\ EJ?_ '97Z944<\@Y4?F;_P 0Z?\ U6+_ ,M3_P"[*/\
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M9_\ !NGT^,7_ '!?_<A42=D5'</^(=/_ *K%_P"6I_\ =E'_ !#I_P#58O\
MRU/_ +LK],J*QYY&G*C\S?\ B'3_ .JQ?^6I_P#=E'_$.G_U6+_RU/\ [LK]
M,J*.>0<J/S-_XAT_^JQ?^6I_]V4?\0Z?_58O_+4_^[*_3*BCGD'*C\S?^(=/
M_JL7_EJ?_=E'_$.G_P!5B_\ +4_^[*_3*BCGD'*C\S?^(=/_ *K%_P"6I_\
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MK^ABL*FYK3V"BBBLRPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%1116)H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG_Z/2N8^;VKI_@K_ ,EC\)?]AFS_ /1Z4@/Z/J***Y3H"BBB@ HHHH ****
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M_L6+'_T2M>P5X_\ \$_?^3(?A5_V+%C_ .B5KV"N0WCL%%%% PHHHH ****
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MS>U?IG_P;I]/C%_W!?\ W(5%3X2H[GZ94445SFP4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PO[4'_)M/Q$_[%G4O
M_266OYU/F]J_HK_:@_Y-I^(G_8LZE_Z2RU_.I\WM6U(SJ!\WM1\WM1\WM1\W
MM6IF'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0!Z;^Q3_P GD?"7_L<M'_\
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M_P#H]*YCYO:NG^"O_)8_"7_89L__ $>E(#^CZBBBN4Z HHHH **** "BBB@
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MBFNZQ(S,P55&22> * &WEY#IUI+<7$L<-O"ADDDD8*D:@9))/  '.37X&?\
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MT>WT^ZEM+&S:!Y(T"L4+72L5R.,J#["N\_XB /@W_P!"S\3/_!=8_P#R77Y
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M>S0<[/U__P"(@#X-_P#0L_$S_P %UC_\ET?\1 'P;_Z%GXF?^"ZQ_P#DNOR
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M0>"#51E9W$U<_F@^;VH^;VKZQ_X*I?\ !/N;]C[XH#7/#]O*_P /?$\[&P8
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M!\&_^A9^)G_@NL?_ )+K\@/F]J/F]J/9H.=GZ_\ _$0!\&_^A9^)G_@NL?\
MY+H_XB /@W_T+/Q,_P#!=8__ "77Y ?-[4?-[4>S0<[/U_\ ^(@#X-_]"S\3
M/_!=8_\ R71_Q$ ?!O\ Z%GXF?\ @NL?_DNOR ^;VH^;VH]F@YV?K_\ \1 '
MP;_Z%GXF?^"ZQ_\ DNC_ (B /@W_ -"S\3/_  76/_R77Y ?-[4?-[4>S0<[
M/U__ .(@#X-_]"S\3/\ P76/_P ET?\ $0!\&_\ H6?B9_X+K'_Y+K\@/F]J
M/F]J/9H.=GZ__P#$0!\&_P#H6?B9_P""ZQ_^2Z/^(@#X-_\ 0L_$S_P76/\
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M<G1K9N?*'I*W!<]1]WLQ;QS_ ()+_L#?VM<6?Q6\8V2M:PGS/#EC.F?.<?\
M+XZG^%?^68/4_/QM0G]&J_I#PFX!]E&.>9A'WG_#B^B?VWYO[/9:]5;^-?'[
MQ6^L3GPOE$_<B[5I+[37_+M/LG\?=^[LG<HHHK]\/Y1"BBB@ HHHH **** "
MBBB@ HHHH *X/]I/X#:3^TK\&M:\(:LJK'J46;:XVY:SN%YBF7W5L9 ZJ67H
M37>45SXK"TL31EAZ\>:,DTT^J>C1U8''5\'B(8O#2<:D&I1:W33NG\F?S_\
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MIMW&.6:'?[_>Z^O.9]FQ^T1^Z-%?BG9?\%O?CY:VRI)K'AZY89_>2:-$&/\
MWS@?I27_ /P6[^/EY!MCUGP_:MG.^+1H2WT^;</TH]FQ\Z/VMJ#4M2M]'L);
MJ\N(;6U@4O+-,XCCC4=RQX ^M?A1XL_X*O?M!>,XVCN/B/J5K&V<+86=K9%
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MSI&AEUY%NC9N)1[/(J(#U'DOV:OT:KGJ/6QM%:!1114%!1110 4444 %%%%
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MWM1\WM1\WM0!)9V<VH7<5O;Q23S3N(XXXU+/(Q. H Y))(&!UK]J_P#@E/\
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MFS_]'I7,?-[5U?P(LY-1^.'@VWA7S)KC7;&.-<@;F-P@ R?>D!_1U1117*=
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MWA?P$\VK_P!HXZ/^SP>B?VY+I_A77N_=[V_GOQQ\5ED&$>3Y9/\ VNJM6O\
MEW!]?*<OL]4O>T]V^U9V<.F6<-O;PQ6]O;HL<44:!4B0# 50.  !@ <8J:BB
MOZN225D?P8VV[L****!!1110 4444 %%%% !1110 4444 %%%% %;5-,MM;T
MRXLKR"&ZL[R)H)X95#1S(PVLK \$$$@@^M?BM^WC^RK<?LF?'B^T>)97\/:G
MF^T6=OFWV[,?W9;N\9RI[XVMQN%?ME7AW[?O[*$'[67P&O=+MXX_^$FT?=?Z
M),<*1.!S"6/1)5^4Y. =C'.T5^=^)/"*SO+&Z*_?TKRAW?>/SZ>:7F?L'@OX
M@OAG.U'$R_V:O:-3M'^6?_;K>O\ =;ZV/Q4HJ:_L9M+OIK6YADM[BW=HI8I%
M*O&ZG!4@\@@@C%0U_'#33LS_ $8335T%%%%( HHHH **** /</V OVKY_P!D
MWX]6>J7$DA\,ZQML=<A7)'D$\3!1U>)OF&!DKO48W&OVEL;Z'5+*&ZMIH[BW
MN$66*2-@R2HPR&!'!!!!!K^>JOTW_P"".7[7W_"<^"I/A?KEUNU;P]$9M&>1
MN;FS!^:$>K1$\#KL8 <(:_=_!OC#V%9Y'BG[LW>FWTEUC_V]NO[U^LC^6?I&
M>'OUK#+B? Q]^FE&JEUATGZPV?\ =:>T3[EHHHK^E3^+0HHHH **** "OF7_
M (+%?\HX_B-_W#?_ $YVE?35?,O_  6*_P"4<?Q&_P"X;_Z<[2JCN@/PT^;V
MH^;VH^;VH^;VKI.</F]J/F]J/F]J/F]J #YO:CYO:CYO:CYO:@ ^;VKI_@K_
M ,EC\)?]AFS_ /1Z5S'S>U=/\%?^2Q^$O^PS9_\ H]*0']'U%%%<IT!1110
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M=I'96D"_\LXT4*O/<\<D\DDD\FMBBBN<V"BBB@ HHHH **** "BBB@ HHHH
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M--+^#7PTT+PIHL9ATOP_916-L&.6*HH7<Q[LV"Q/<DFNAKF;N[G0M$%%%%(
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M1W0'X:?-[4?-[4?-[4?-[5TG.'S>U'S>U'S>U'S>U !\WM1\WM1\WM1\WM0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#^?G_@H'_R>Y\5?^QFOO_1K5Y!\WM7Z(_M4_P#!
M&CXO?&;]I'QQXLTBY\'KI?B+6;F_M1<:C*DHCDD++N41$!L'IDUP/_#ASXW?
M\_?@7_P:2_\ QFNA21CRL^+/F]J/F]J^T_\ APY\;O\ G[\"_P#@TE_^,T?\
M.'/C=_S]^!?_  :2_P#QFGS(.5GQ9\WM1\WM7VG_ ,.'/C=_S]^!?_!I+_\
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M/C=_S]^!?_!I+_\ &:/^'#GQN_Y^_ O_ (-)?_C-',@Y6?%GS>U'S>U?:?\
MPX<^-W_/WX%_\&DO_P 9H_X<.?&[_G[\"_\ @TE_^,T<R#E9\6?-[4?-[5]I
M_P##ASXW?\_?@7_P:2__ !FC_APY\;O^?OP+_P"#27_XS1S(.5GQ9\WM1\WM
M7VG_ ,.'/C=_S]^!?_!I+_\ &:FL/^""/QJO)]DFJ?#^U7&=\NIW!7Z?+;L?
MTI<R#E9\3?-[5>\+^%M2\;>(;32='L+S5-4U"00VUI:Q-+-.YZ*JKDDU^B_P
MJ_X-ZM2ENX9?&_Q"LK>!2#+:Z'9M*\@[A9IMH7ZF)OI7W%^S!^PO\-/V1-/V
M^#O#\<6IR1^7<:O>-]HU"Y'<&4_<4X&4C"(2 =N:3J);#4&>!_\ !*[_ ()?
M?\,LVJ>.O'$4%QX_OH2EM: K)'H,3C# -T:=AD,P.%!*C.6)^VJ**Q;N[FNP
M4444@"BBL;X@76N6?@C5)/#5K8WWB!;=_P"SX;V8PVSSXPGF,H)" X)P"2!Q
M0!\A_P#!7C_@H:/V:? 3>!?"=]M\>>)+8^=/"WSZ):-P9,_PS.,A.ZC+\83/
MXWLVXY/)/))[U]W?$G_@C%^T1\7?'FJ^)O$6M>"]3UK6KAKF[N9-5EW2.>P'
MDX"@8"J,!5  P !6)_PX<^-W_/WX%_\ !I+_ /&:WBXI&4KL^+/F]J/F]J^T
M_P#APY\;O^?OP+_X-)?_ (S1_P .'/C=_P _?@7_ ,&DO_QFJYD+E9\6?-[4
M?-[5]I_\.'/C=_S]^!?_  :2_P#QFC_APY\;O^?OP+_X-)?_ (S1S(.5GQ9\
MWM1\WM7VG_PX<^-W_/WX%_\ !I+_ /&:/^'#GQN_Y^_ O_@TE_\ C-',@Y6?
M%GS>U:7@WP=JGQ"\5Z?H>B6-QJ6K:M<):VEK NZ2>1CA5'X]SP.^*^P?^'#G
MQN_Y^_ O_@TE_P#C-?7O_!+_ /X)92?LB:I?^+O&\FE:IXVDW6NG"T=IK?2[
M<C#.K,JDRR9()Q\JC /S-2=1) HL]9_X)Z_L/Z7^Q+\%H=,_T>\\6:P$N=>U
M%!GS9L<0QDC/DQY(7.,DLV 6P/?***Y]S8**** "BBB@ HHHH **** "BBB@
M HHHH **** "J'B?PQI_C3PY?:/JUG!J&EZG ]K=6TZ[HYXG!5E8>A!(J_10
M!^.?_!0S_@D)XA_9WU"^\5?#VUOO$G@0DS2VR9FOM%'4AP/FDB'.) "5 ^?I
MO;XF^;VK^F6OF_\ ::_X)4_!_P#:<O)]1O-$D\,^()R6?4]"9;629O62,J8I
M"3U8IO/]X5K&IW,Y0['X5?-[4?-[5^BOQ$_X-Z/$UG<2-X3^(>@ZA$>8TU>R
MELV7KP6B\W/;G:/IVK@]0_X((?&JRE58]6^'UX&&2T6IW( ]OGMU/Z5?.B>5
MGQ-\WM1\WM7VG_PX<^-W_/WX%_\ !I+_ /&:/^'#GQN_Y^_ O_@TE_\ C-/F
M0<K/BSYO:CYO:OM/_APY\;O^?OP+_P"#27_XS1_PX<^-W_/WX%_\&DO_ ,9H
MYD'*SXL^;VKZ]_X)/?\ !0>3]DKXE_\ ",^);IO^%?>*)U%RSG(T>Y.%6Z'^
MP1A9!_= ;DIAM;_APY\;O^?OP+_X-)?_ (S1_P .'/C=_P _?@7_ ,&DO_QF
MDY1:L"31^QUO<1WD$<T,B2PRJ'1T;<KJ>001U!J2OG7_ ()R?";XM_ +X0MX
M+^)TVA:E::+M30[VQOWN)DM^0;>0-&ORI@;#D_*=O 5<_15<YL%%%% !7YO_
M /!Q#_R)GPM_Z_-1_P#0+>OT@KY"_P""LW[#GC3]M?P]X)M?!TNB12>'[B[E
MNO[1NG@!$JQ!=NU&S]PYZ=JJ.Y,MC\5_F]J/F]J^T_\ APY\;O\ G[\"_P#@
MTE_^,T?\.'/C=_S]^!?_  :2_P#QFM^9&?*SXL^;VH^;VK[3_P"'#GQN_P"?
MOP+_ .#27_XS1_PX<^-W_/WX%_\ !I+_ /&:.9!RL^+/F]J/F]J^T_\ APY\
M;O\ G[\"_P#@TE_^,T?\.'/C=_S]^!?_  :2_P#QFCF0<K/BSYO:CYO:OM/_
M (<.?&[_ )^_ O\ X-)?_C-'_#ASXW?\_?@7_P &DO\ \9HYD'*SXL^;VH^;
MVK[3_P"'#GQN_P"?OP+_ .#27_XS1_PX<^-W_/WX%_\ !I+_ /&:.9!RL^+/
MF]J/F]J^T_\ APY\;O\ G[\"_P#@TE_^,T?\.'/C=_S]^!?_  :2_P#QFCF0
M<K/BSYO:CYO:OM/_ (<.?&[_ )^_ O\ X-)?_C-'_#ASXW?\_?@7_P &DO\
M\9HYD'*SXL^;VH^;VK[3_P"'#GQN_P"?OP+_ .#27_XS1_PX<^-W_/WX%_\
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M(.5GQ9\WM1\WM7VG_P .'/C=_P _?@7_ ,&DO_QFC_APY\;O^?OP+_X-)?\
MXS1S(.5GQ9\WM1\WM7VWIO\ P0.^-5]*RRZO\/;-5P=TNI7+!OILMV_7%>M?
M"'_@WLCAO8Y_'GQ ,UNK O9Z%:;6<?\ 7>;./^_1I<Z#E9^<_P -/AAX@^,G
MC2Q\.^%](O=<UK47\N"UM8]SMZDGHJCJ68A5 )) !-?M'_P32_X)R:?^Q-X+
MFU35VM=4^(&N0A+^\C&8["+AOLL)/50P!9\ N0.RK7K_ .SO^RAX _97\.-I
MO@?P[::2LP N;HYEN[PCO),V7;GD#.T9X KT:LI3OH:1C8****@H**** "OF
M7_@L5_RCC^(W_<-_].=I7TU7C7_!0'X#:Y^TW^R+XN\#^&VL8]:UO[']G:\E
M,4 \J]@G;<P5B/DC;'!YQ]:<=P/Y_P#YO:CYO:OM/_APY\;O^?OP+_X-)?\
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M:ZH_LWZ-O GL,-/B?%Q]ZI>%*_2*?O2_[>:Y5ULGTD%%%%?@I_58445]>?\
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M-\-O#%IHOA_2['1=)L4V6]G9P+##$/95 ')R2>I)).:UJ**S*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &3XI\!Z'XXM_)UK1=)UB'&-E[:1W"XY[.".Y_,U
MYKXE_8 ^"?BQV:\^%O@A6<Y9K;2HK5F//),04YY/U_ 5[!11=@?-&L?\$?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX/\ >23TJ27V5WA%_*4M=DFRBBBOVT_F8**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR;U;;U;;[MA1116QSA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M?_A=A5TP=F__L?%%4';PZU_(+U!+ P04    " "<@:50F5R<(Q &  "<)P
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M(9+CR^^9]9@\4_-NSG;2O0KWS"Q>F=E'F1;)PY:9$(<101<(,B,24WL6H*@
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MH,?MUJ[&"HZTKC"X.<?!]3[[#U!+ P04    " "<@:50NJ$YBM<!   R!@
M#0   'AL+W-T>6QE<RYX;6S555N+U3 0_BLA/\"<=MD%I2WHPH*@LK#GP=>T
MG;:!W$RGQW9_O4G3V]$'\>"#OC0SWTR^^7*9-.MQDO#2 2 9E=1]3CM$^XZQ
MONI \?Z-L:!]I#%.<?2N:UEO'?"Z#Y.49.GI], 4%YH6F1[4D\*>5&;0F-,3
M9476&+TC=S0"/I4K(!<N<_K(I2B=F'.Y$G**<!J RDCC"'HID-,D(/UK#"?1
M"RH7'B6T<0%DL4+\EDOZ3X'5Z[TKI-P$IC0"168Y(CC]Y)TY>09_"9'%/D_6
M*VP=GY+TGNX3YL$7*8VKP6UE$KI"12:A"7*<:+LPHK$L!!&-\D8M>&LTGS6L
M,Q;#TU8@Y4LXPJ_-%??8D)CSL0['0(**U?2K7LQX7-$)_$>VR'V@O;^)EEAQ
M,?AA\*O1L_]M, C/#AHQSO[8;/4].[=63N^E:+6"N);?%DQN+%AD?*U#.N/$
MJ^<+-Z7R #A*+N!05$?DN^/V#".NMVEL;M6<_H>:__8^MZ#!<7D4[:_^O[S+
M?Z*8+=US:-&K!MU04@Y"HM"+QD[4-41YX87,Z9?P\,JK/MG[U-,C+_T#?L7O
MY];0\$'B<UCQ',SI;G\*+TWRL&6=-XJ<[O9GJ,6@WLX%][]$\0-02P,$%
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MH(/Z+7#Y@(=[JS5G,22>\?W#Z#'XVANS"-B[>R6=^"/'\$?S'U!+ P04
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ML)\)VV$]=N'?(*EA.N_6_VATF<N@7?S-R$=*[4%?#?_)\@M02P$"% ,4
M" "<@:50'R// \     3 @  "P              @ $     7W)E;',O+G)E
M;'-02P$"% ,4    " "<@:50)^B'#H(   "Q    $               @ 'I
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )R!I5 CD8,M[@   "L"
M   1              "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( )R!I5"97)PC$ 8  )PG   3              "  ;8"  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ G(&E4+1R'#>? @  DPL  !@
M         ( !]P@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( )R!I5#- ,A,4@(  .0%   4              "  <P+  !X;"]S:&%R
M9613=')I;F=S+GAM;%!+ 0(4 Q0    ( )R!I5"ZH3F*UP$  #(&   -
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64$L%!@     *  H @ (    4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "exel8-k20200331earning.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "exel-20200505_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "exel-20200505_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "exel8-k20200331earning.htm"
     ]
    },
    "labelLink": {
     "local": [
      "exel-20200505_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "exel-20200505_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "exel-20200505.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd",
      "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "exel",
   "nsuri": "http://www.exelixis.com/20200505",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel8-k20200331earning.htm",
      "contextRef": "D2020Q1FilingDateFeb25",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001000 - Document - Cover Page",
     "role": "http://www.exelixis.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "exel8-k20200331earning.htm",
      "contextRef": "D2020Q1FilingDateFeb25",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.exelixis.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>exel8-k20200331earning_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="exel-20200505.xsd" xlink:type="simple"/>
    <context id="D2020Q1FilingDateFeb25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000939767</identifier>
        </entity>
        <period>
            <startDate>2020-02-25</startDate>
            <endDate>2020-02-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="D2020Q1FilingDateFeb25"
      id="Fact-B009F6502E91531CA4034DACC2DAB111-wk-Fact-B009F6502E91531CA4034DACC2DAB111">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="D2020Q1FilingDateFeb25"
      id="Fact-357635042E365E458E0FADCD8000162B-wk-Fact-357635042E365E458E0FADCD8000162B">0000939767</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e94-wk-Fact-FAAA2382A52658889BD02246FE081083">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e108-wk-Fact-0FF9041A61765569BC070A97F3C41505">2020-05-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e127-wk-Fact-D6C83FEFFB365C57A61FB08CE9C7F495">EXELIXIS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e151-wk-Fact-071C00B831325ECA8A8EBB3708996183">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e156-wk-Fact-9954CCAA14955AED823992FE42761175">000-30235</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e161-wk-Fact-D8D70467F6655119B943D18F3702086B">04-3257395</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e183-wk-Fact-914D1D53B56550C19A2F2803EB3949D6">1851 Harbor Bay Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e189-wk-Fact-B54F1DFAAF13578CAB8A694B3E84A96E">Alameda</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e194-wk-Fact-57AC12EEB1545CEC8282C9430C108890">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e199-wk-Fact-65599BF0EC165C3EAE92D3F313092C30">94502</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e212-wk-Fact-7F1FF692A5D0536685DC3F197B052367">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e217-wk-Fact-C032DFA6A5BF54C29FE76F0A86AB6320">837-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e229-wk-Fact-29B8AB0A6AD7547BA6568CA8CBC19DFE">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e237-wk-Fact-6BEBD67F9AB0517BB956C54027569CEC">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e245-wk-Fact-6C64C835E2035C95A6F6356D838093A0">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e254-wk-Fact-5A693EB7870E5691BA41D4358C13A99D">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e296-wk-Fact-03D10DAEE4FC5A1EB6C82EF6FB4ED525">Common Stock $.001 Par Value per Share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e301-wk-Fact-E4ED733214BA50BB9FA9941AF3B5F022">EXEL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e306-wk-Fact-6A5FFF26E9D259DB8BFF3C75B56E35D4">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="D2020Q1FilingDateFeb25"
      id="d112073006e315-wk-Fact-A250BB673C8B5212B1E34062AA6F8C67">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6606944512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Feb. 25, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  05,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EXELIXIS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000939767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock $.001 Par Value per Share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EXEL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3257395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1851 Harbor Bay Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alameda<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">837-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="exel8-k20200331earning.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.exelixis.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="exel8-k20200331earning.htm">exel8-k20200331earning.htm</File>
    <File>exel-20200505.xsd</File>
    <File>exel-20200505_cal.xml</File>
    <File>exel-20200505_def.xml</File>
    <File>exel-20200505_lab.xml</File>
    <File>exel-20200505_pre.xml</File>
    <File>exel20200331exhibit991.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>exellogo18q3a15.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000939767-20-000067-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000939767-20-000067-xbrl.zip
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M?]':WWA0^V\M9PGP#E0)9109T;N=CSM?4$L#!!0    ( )R!I5"_(8)AG $
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MXG[C=!;:'QJN>+C1AGZZ4P>NW_[=VPQ0.5 ,6,S1(2>W:*_V#E!+ P04
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MJ7 ATRZ49Q0\.I$ ]\YD(C.#/I5(TQ 62?O2[&MY7M)?.9MO&L5FC /7=^S
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MQ?Q4U\(1>.B=SO))7N?%S5\9:[P\FZ78=F!HF(%IA8;CA)%EA)V1/-,/N!\
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M+O>".@@$N&R0?M:W]+= 8*>U0! GZLO]_%;I@P7 +[.0^@"9_<EU FH+Z@I
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MX#X/10>3Q7NTO@XFM:*#R=I.K>A@4G0P62^<Z[0#$CMNAHLG9=G<#969-Q"
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M6D[HUA=HY>,@ UUI9&4NU6UI22DYFFH "@:0;[2$SQ>W>BH$C@K(#DKDH\K
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M)79+BK[?$:U>[/&RKC_VNM*L(%O;^MV=**S6%OZ *)VF^?!L1G!6YP1/*$R
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MEHY*A).02&> (*L$X8;M#%%->/,-WNMHLUZ'0;F#]2!!6!E%#1&0F1AH3@+
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M-1OY2L3&*#5K(UY4%+H2$/QLB"ZFS%8G1&="+I#54&Q8%SU1R4)F*HX,R U
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M6E'\><U3(.ADC"6*]1A3M,#^*APIP80G&RC9\QW?ZV3-C@Q,QUMIO2@QMH+
MUHA<TMXV*Y*4D1K- D96#6?(K];RDI]QA TZXX$XM,9Z@$?6=%^":G+II ,/
MY3N_&14"@'I[Q9'WI6U"B;."K*_DIBDQ[L-B-J2<*@N)0,IBKH=R;*R9B*95
M/:4'_'R;BEO(? 41R_8LJ;E#05>Z#3P2Q*5AI>E(PS809=P5C]QB,JK?[FMY
ML&;##OQ>U4&72K4L@D5C%6<S*Y(Y*UJA"W# W0:!IQSRE)P9LS,GER&@O:KD
M++!F2!']D-JV)3'.;(EGT:1FCZ&%O)H-(9B_[-32M315+4D6S HTR"^T8-S
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M],BD3R:/GWS$Y,+D\R<_,/FC*6.GS)TB3SE_RLHIZ_OV[B/ZU+Z+^A[MVW#
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MF#?GAJXM'Y_\V<*GQGUEN)X8NG+2FZ]Y#WMT.?+D09\'3QS]S@<35S^\[)/
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MQ98RCNJ5"?.-H^I&^/ SSPOTN3R"R>I0K:Z3\NU2&^MLR92W06Q?SSTX<;"
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MWHP;IH0Q>N@@G!&C">NT1*E!<I8#E8.@CG(!)J=G6HM))O$E+*JL@\G2_>L
MUSH/G>.W3._1WRNGD+S@H9HP 7OOB$$HN9K$$?UX]:'@X9AU&5GU@="]MS.[
MPL?*XU6=YV]>/3<H1?X^WAARK K&KJ:7W<C(T^S*QN!8U.K9B\&(5@9K&UZK
M:.W2$<Z/TJY_&S\5GZ CWI?_I?1M#]<?R&'6WU#%3RQ_['#HT8-1DZL:G$R@
M?RJ9"<RY*M+WFZZU4[E!#CZ) #TZY[L6$^B:==P^DBGI[*@/^J34V9I_[R73
MC/EW'RN#OMRQLFP3J,CZK*?055)3%[SO@7@'H$\PD:I&X5,3U-X3VA>Y2/(&
M10_,Q+IP>BT;.Y<?+EFLQW<60T*QA79+I]*0?;!\V*MR6X\U=HOFUJ.V96C*
M6FYHY/Z[KJSPUO[YY9D*3_??<-U2>^:/QQ7_9\RWA%;#MJ21X$*_M:$9$=>F
M-?XJ-0Q9MC7 ];V9_4W7J;$RV,2I(HU4$QIK<5%.@!+)-'!S[&'N(65M/')U
M3",JC25M1]]9CSU8?F>GSWG%4?S)4:?NWX^ZNE#P.GSOB74A;&(P#61HOM6,
M)A@Q$RDL5^=S$.?L-U[2XJ!SE%88-\DKMQZ_<VPE8V9E!\R7TES-Z(MJ/YVS
MF6QK()LS)Q?;WC)RF&ZV[D)BG]\88Y](6=8K,81_+GJC+DJ26Q$KBB3I<1O
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MH,GS$DDE-Y[_F8!DR@5!.=<A?@RV'C6M<2>3=LU.A>+6(F5WN8)#SP"W!^*
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MX(B.T _M-*2]0=ITLB/:L7ME47O(][ZV9,Q%T%=LF#[7Q%5$^NR=Q_NH//[
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MC0?U8L*QEZ(C(9^4/15K93@,N%]$15\.;=-;&O%RGJX/.I7O]^IGD>N_38V
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MAIBSDXQBR='AZD]5[@2!Z,[T'^!" [6[X)?[J*(3#B(]ZWE'W'8W:D6K] &
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M%H%C]Q>L_V$B9$R0&CW;E!?% ,6&>B&M"C?*[+>'_3T!]_^UG,V: H$?Z66
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M!HS!$*YV( 8:,>\'ZD>"97B?0]AOF)?%7%7^:-(:53$#=T3!UV954C!22%P
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MQ^_"56$OS 7R%YWK"?B^Z[*;Z#-NB3-,,<\BW6CU0Y2W)I-T"4(X*8R9HGL
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M^"O13]HQ= <#1#X70+_4Z8]9W\QD@&:/K.M_C;N/L/@9LMSYW>K>OZ78FW$
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MH+A_@\OY% F:B[!0CE^%=$%WPR_>U(L\[9T%X[C8A?*1*H)0?,0ARZ*%MCF
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MD$]X?4 %/M61I8F:$_S;J<UZX.N^Z9B%-Q.&3$,7B7/]M:[D9 #9UAR.I.C
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MR$^^=:2<\[O4R1J_S 5-\O=;?/:RJ.W(A<VI8>24_\+\7NN.[,^]YMQ_<RJ
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M'1QPVR+I6NR#3:UED=*;:882?1/1+1Q,:#VMTVKG&_JH#%EV,\H@3?FK,'-
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M)27#WJE$WXEW;S:%IF'%,QP613=YUB1,HG2OMHAF5 42;I'C2-=V(7XVW7[
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M#)?LT[]M\_I1MBT8JEZ52MR4X=J."A,A6LFUY\YX+;PE:6YEK,X/BO/GQ<>
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M_NEUM];AF[#9U"W0EW+%6X&[P(E5)@,B^'I1UT:;@>@3LA(KLA09=*7YJ"U
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M;"TR,#(P,#4P-5]L86(N>&UL4$L! A0#%     @ G(&E4(G@^*%2!@  "#4
M !4              ( !71   &5X96PM,C R,# U,#5?<')E+GAM;%!+ 0(4
M Q0    ( )R!I5#Q.(_=SC@  )69 @ :              "  >(6  !E>&5L
M,C R,# S,S%E>&AI8FET.3DQ+FAT;5!+ 0(4 Q0    ( )R!I5 "#C+9\1D
M *#$   :              "  >A/  !E>&5L."UK,C R,# S,S%E87)N:6YG
M+FAT;5!+ 0(4 Q0    ( )R!I5!AT2J161$! ,+& 0 3              "
M 1%J  !E>&5L;&]G;S$X<3-A,34N:G!G4$L%!@     (  @ ' (  )M[ 0
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
